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Abstract 
The Gram-negative bacterium Bartonella henselae (Bh) is an emerging zoonotic 
pathogen that has been associated with a variety of human diseases including bacillary 
angiomatosis which is characterized by vasoproliferative tumor-like lesions on the skin 
and internal organs of some immunosuppressed individuals. Several virulence factors 
associated with Bartonella-induced pathogenesis have been characterized. However, 
the study of those virulence factors has been limited to in vitro cell culture systems due 
to the lack of a practical animal model. Therefore, we wanted to investigate whether the 
zebrafish embryo (Danio rerio) could be used to model human infection with Bh.  We 
investigated if Bh can mount an infection in zebrafish embryos during their early stage 
of development. Our data showed that Tg(fli1:egfp)y1 zebrafish embryos supported a 
sustained Bh infection for 7 days with >10-fold bacterial replication when inoculated in 
the yolk sac. This was evident by plating of zebrafish homogenates, quantitative PCR, 
and confocal microscopy analysis. We assessed the interaction of Bh with EC and the 
phagocytic cells in live embryos by microscopy. Our data showed that aggregates of Bh 
interact with the endothelium of the embryo vasculature. Evidence showed that Bh 
recruited phagocytes to the site of infection in the Tg(mpx:GFP)uwm1 embryos. We 
also wanted to determine the response to infection with Bh. Infected embryos showed 
evidence of a Bh-induced angiogenic phenotype as well as an increase in expression of 
genes encoding pro-inflammatory factors and pro-angiogenic markers. A deletion 
mutant for the entire VirB type IV secretion system (ΔvirB2-11) supported bacterial 
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replication although to a lesser degree compared to the wild type control.  However, 
infection of zebrafish embryos with a deletion mutant in the major adhesin (BadA) 
resulted in little or no bacterial replication and a diminished pro-angiogenic and pro-
inflammatory host response compared to wild type Bh, providing the first evidence that 
BadA is critical for in vivo infection. Thus, the zebrafish embryo provides the first 
practical animal model of Bh infection that will facilitate efforts to identify virulence 
factors and define molecular mechanisms of Bh pathogenesis. 
 
1 
 
 
 
Chapter 1 
Introduction 
1.1. Bartonella species, their hosts and human diseases 
 Bartonella are small, pleomorphic Gram-negative rod-shaped bacteria which 
belong to the α2 subgroup of the class Proteobacteria [4]. Bartonella formerly known as 
Rochalimaea are closely related to the genera Brucella and Agrobacterium [5]. To date, 
over 30 species or subspecies of Bartonella have been identified and classified using 
molecular methods such as PCR using specific primers to Bartonella 16S ribosomal 
DNA and the tmRNA gene (ssrA) [5,6]. As the development of new molecular methods 
improves, it is expected that the number of identified Bartonella species will increase. 
The genus Bartonella includes fastidious, facultative intracellular bacteria that are 
associated with endothelial cells (EC) and erythrocytes of a variety of hosts including 
rabbit, cat, rodent and human (Table 1.1) [3,7-9]. All of the identified Bartonella species 
have been associated with mammalian hosts and at least 12 of them are identified as 
human pathogens. B. bacilliformis and B. quintana have been isolated from humans 
[10,11]. Bartonella vinsonii subsp. berkhoffii has been isolated from dogs [12]. B. 
henselae, B. clarridgeiae and B. koehlerae have been found in cats [13-15]. B. doshiae, 
B. grahamii, and B. vinsonii subspecies vinsonii have been isolated from voles [5,16]. B. 
elizabethae, B. taylorii, B. birtlesii and B. tribocorum have been recovered from rats 
[5,16-18]. B. vinsonii subsp. arupensis was isolated from mice [19].   
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Table 1.1. List of Bartonella species (subspecies), their natural hosts, 
vectors, and human diseases. Over 30 species and subspecies of Bartonella 
have been identified worldwide. More than 25 of those species have been 
associated with mammalian hosts and at least 12 of them are identified as human 
pathogens causing a wide array of diseases in human. Table reproduced From 
Vayssier-Taussat et al. 2009  with authors’ permission [3].  
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Bartonella are emerging pathogens that are involved in a number of disease 
manifestations in humans and animals. Infections caused by this group of bacteria 
range from chronic bacteremia with no apparent symptoms in their reservoir hosts to 
self-limiting regional lymphadenitis and more complicated endocarditis in the human 
host [20-22]. Although mammals seem to be an important reservoir host for Bartonella, 
most of the human diseases are caused by only three species: B. bacilliformis, B. 
quintana and Bh. 
Humans are the only known reservoir for B. bacilliformis, the bacterial agent of 
the biphasic disease bartonellosis (Carrion’s disease). The bacteria are transmitted 
between humans through bites of infected female sand flies Lutzomyia verrucarum 
[23,24]. Once the bacteria enter the human blood, they colonize almost all of the 
erythrocytes leading to an acute and severe hemolytic anemia causing a wide array of 
symptoms including myalgia, fever and headache; this phase is known as oroya fever 
[25,26]. The second phase of the disease is verruga peruana, which may be sequential 
or independent of Oroya fever, and is characterized by non-fatal tumor-like lesions seen 
mainly on the skin [27-29]. An outbreak of bartonellosis resulting in more than 7000 
deaths was reported in 1871 in the high-altitude valleys and remote areas of South 
American Andes [30,31]. Mortality during the acute phase of bartonellosis ranged from 1 
percent in the case of patients receiving antibiotic treatment to 88 percent in the 
untreated although some of the mortality might be attributed to secondary infection with 
bacteria and viruses [10,30,32]. 
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Like B. bacilliformis, humans are the primary reservoir for B. quintana. The 
pathogen is transmitted between humans by the body louse (Pediculus humanus 
corporis) and historically known to cause trench fever, characterized by a recurrent and 
cycling (every 5-day) fever in the human host [33]. Approximately 1 million people in 
Europe were affected by trench fever during World War I [34]. Although the incidence of 
trench fever has substantially declined since World War I, the condition has reemerged 
as urban trench fever among the poverty-stricken, alcoholic and homeless individuals 
living in poor health and hygienic conditions [35]. Moreover, for the past two decades, B. 
quintana have been associated with other infections namely endocarditis, chronic 
bacteremia primarily among the poor and bacillary angiomatosis in immunosuppressed 
individuals [36-39].  
While humans are the reservoir hosts for B. bacilliformis and B. quintana, cats 
are the natural host for Bh in which the bacteria cause an asymptomatic 
intraerythrocytic infection [14,40]. The organism, however, can be transmitted between 
cats through cat fleas (Ctenocephalides felis), and from infected cats to humans by 
bites and scratches (Fig. 1.1) [41,42]. Although infected cats show an asymptomatic 
bacteremia, this zoonotic pathogen can cause a wide array of infections in the human 
incidental host. Immunocompetent patients infected with Bh typically suffer from cat 
scratch disease (CSD) which is a benign subcutaneous lymphadenopathy associated 
with fever [43,44]. It is estimated that 22,000 – 24,000 cases of CSD are diagnosed 
yearly, mainly in children, in the United States [45,46]. Although CSD is considered to 
be a self-limiting infection, over 10% of those cases require hospitalization and if not 
treated the bacteria can disseminate to other organs such as the liver, the brain and the 
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heart leading to more serious complications [12,45]. Immunosuppressed individuals 
such as HIV patients infected with Bh can develop a more systemic infection 
characterized by vasoproliferative tumor-like lesions called bacillary angiomatosis (BA) 
and bacillary peliosis (BP) on the skin and liver, respectively [47]. According to the CDC, 
the exact incidence of BA and BP is not known; however, cases have been reported in 
all 50 states in the U.S., with the majority in men because of the disproportionate 
incidence of HIV in men. 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
Figure 1.1. Bh infection in cat and the human incidental host. Bh causes 
intra-erythrocytic bacteremia in cats. Infection is spread between cats through the 
cat flea vector. The pathogen is transmitted to the human incidental host by 
scratches or cat bites from an infected cat. Immunocompetent individuals 
develop cat scratch disease and immunosuppressed individuals develop bacillary 
angiomatosis. Figure copied from Dehio, 2005 with author’s permission [2]. 
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1.2. Bh pathogenesis and infection strategy 
 
 Upon inoculation of a mammalian host, Bartonella are believed to reside in what 
researchers call a “primary niche”, outside of the bloodstream partly to avoid elicitation 
of a host immune response as the bacteria are not capable of directly invading the 
erythrocytes until the host or the bacteria are primed to do so [48]. The nature of this 
primary niche in Bartonella infection has not been completely established yet. This is 
perhaps, in part because infection strategy and host-pathogen specificity differ among 
species, and in part because of the lack of a suitable animal model. Although the 
cellular composition of the primary niche is not completely clear, in vitro data suggest 
that it may involve EC, migratory cells such as lymphocytes and mononuclear 
phagocytes which may play a role in the transport of the bacteria into the microvascular 
environment [2,20]. 
Bh is thought to be transmitted to the human incidental host mainly indirectly 
through cat flea feces via cat scratches or cat bites [49]. Once the bacteria are 
inoculated, they can invade many cell types including EC [50], hematopoietic progenitor 
cells [51], epithelial cells [8], monocytes and macrophages [52,53]. It has been shown 
that Bh entry into EC can happen by two alternative routes: single bacteria uptake via a 
zipper-like mechanism or as large bacterial aggregates in a structure called the 
“invasome” [54,55]. Bacteria-containing vacuoles accumulate in the perinuclear space 
where they fail to acidify and fuse with the lysosome [48]. Consequently, the bacteria 
are able to replicate and persist in the host cells. Bh was shown to induce the secretion 
of IL-10 in both in vitro and in vivo studies [56,57]. Secretion of IL10, a potent anti-
inflammatory cytokine which suppresses the function of immune cells including 
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macrophages and dendritic cells, may contribute to an asymptomatic and persistent 
course of infection favoring Bh [48]. 
 
Cat scratch Disease 
 CSD is the most commonly known disease manifestation associated with Bh 
infection in immunocompetent individuals. As reviewed by Florin et al., CSD begins after 
3 to 10 days with an erythematous papule at the site of inoculation with Bh, then the 
lesions progress through vesicular and papular crusted stages, and persist for 1 to 3 
weeks [21]. The swelling of the lymph nodes results from granuloma formation via 
recruitment and stimulation of macrophages during an interferon gamma (INF-γ)-
mediated T helper 1 cell response [53]. Moreover, electron microscopy of lymph node 
tissues of patients with CSD show the presence of Bh near the vascular endothelium, 
with organisms seen in clumps in vessel walls [58]. 
 
Bh-induced angiogenesis  
One of the most captivating features of infection with Bh is its ability to cause 
angioproliferative lesions. The pathological lesions seen in BA patients resemble those 
of Kaposi’s sarcoma associated with human herpes virus 8 infection [59]. Histological 
studies revealed the presence of immature capillaries that are lined with swollen 
endothelium in BA lesions, and the lesions are packed with bacterial aggregates and 
infiltrated by macrophages and neutrophils [60,61]. It is believed that live Bh actively 
trigger the vasoproliferative activity since the observed EC proliferation completely 
regresses after treatment with antibiotic [21]. As in tumor angiogenesis, Bartonella-
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triggered neovascularization follows a series of steps that involve disruption of the 
normal pattern of the extracellular matrix and basal membrane, endothelial cell 
migration and proliferation at the site of angiogenic stimuli [62]. Kirby developed an in 
vitro model of Bh-induced angiogenesis and showed that in addition to endothelial 
proliferation, Bh coordinated a series of events which included matrix invasion, survival 
of type I collagen and endothelial tubular differentiation [63]. 
The molecular basis of Bh-induced angiogenesis has been extensively studied in 
cell culture models. Our current understanding suggests that the process involves at 
least three mechanisms that work synergistically: 1) mitogenic triggering of endothelial 
cell proliferation, 2) inhibition of apoptosis (contact-dependent or independent), and 3) 
angiogenic reprogramming of infected host cells (with pro-inflammatory activation of 
cytokines) [64]. Both live and cell extracts of Bh are capable of inducing the proliferation 
and migration of HUVEC [65,66]. For instance, GroEL, a heat shock protein, was shown 
to be secreted in Bh extracts and caused endothelial cell proliferation by triggering the 
release of intracellular calcium [67,68]. EC proliferation was also shown to be 
dependent on anti-apoptotic activity as Bh inhibits the apoptosis of HUVEC by inhibiting 
the activities of caspase 3 and caspase 8 [69]. Bh infection of EC triggers an NF-kB-
dependent release of ICAM-1, E-selectin, MCP-1, and IL-8, some of which may exert a 
direct effect on EC in an autocrine manner leading to cell proliferation, but also may 
recruit monocytes/macrophages and polymorphonuclear cells to the sites of infection 
[1,70-72]. As demonstrated by Resto-Ruiz, the interaction of Bh with the human 
macrophage cell line THP-1 triggered the release of vascular endothelial growth factor 
(VEGF), a potent stimulator of angiogenesis, as well as IL-1β [1]. VEGF acted on EC 
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leading to further cell proliferation and ultimately angiogenesis constituting the paracrine 
angiogenic loop (Fig. 1.2). 
 
1.3. Bh virulence factors 
For the past decade, Bartonella research has been advancing at a fast pace due 
in part to the availability of the complete genome sequence for Bh and the appropriate 
cell culture models [73]. This has enabled the establishment of gene function and 
definition of important virulence factors including secreted factors as well as membrane-
bound proteins associated with Bh-induced pathogenesis for further in vitro studies.  
 
Figure 1.2. Paracrine loop model of Bh-induced angiogenesis. Upon adherence 
to and invasion of macrophages (mac) and neutrophils via BadA, B. henselae 
induced the production of VEGF which functions in a paracrine manner and acts as a 
mitogen to endothelial cells (EC) leading to cell proliferation and angiogenesis. When 
EC are infected with B. henselae through the VirB T4SS and the expression of the 
Bartonella effector proteins (Beps), a cascade of pathways occurs leading to 
production of  pro-angiogenic chemokines and cytokines, which may exert a direct 
effect on the EC or may recruit monocytes and neutrophils to site of inflammation 
leading to further EC proliferation and angiogenesis. Figure is adapted from Resto-
Ruiz et al. with author’s permission [1]. 
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Bartonella adhesin A  
Bartonella adhesin A (BadA) belongs to the class of trimeric autotransporter 
adhesins along with YadA from Yersinia enterocolitica and NadA from Neisseria 
meningitidis. These proteins represents important virulence factors of Gram-negative 
bacteria in the form of an extracellular filament consisting of a head, neck and repetitive 
stalk domains assembled on a C-terminal membrane anchor domain [74,75]. There are 
at least two variants of the badA gene with the best-characterized one, badA full-length 
(BH01510), encoding a large protein made up of more than 3000 amino acids resulting 
in a size of 328 kDa per polypeptide chain and a length of 240 nm [64]. In vitro studies 
of Bh infection have shown that BadA is critical for adhesion to host cells and 
extracellular matrix proteins such as fibronectin and collagens, as well as inhibition of 
phagocytosis and induction of angiogenesis [76]. The expression of BadA has been 
shown to correlate with a pro-angiogenic cell response via activation of hypoxia-
inducible factor 1-alpha (HIF 1-α) and the subsequent secretion of the pro-angiogenic 
factor VEGF [52,76-78]. 
 
VirB/VirD4 type 4 secretion system 
Many pathogenic bacteria utilize a type IV secretion system (T4SS) to 
translocate DNA and effector molecules into the host cells to influence cellular 
functions. The VirB/VirD4 system of the plant tumor-inducing plasmid pTiC58 of 
Agrobacterium tumefaciens is the best-characterized member of this transporter family 
and consists of 10 essential components: VirB2-11 plus the type IV secretion substrate 
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recognition module VirD4 [79]. The T4SS consists of a translocation channel that spans 
both the inner and outer membrane of Gram-negative bacteria and merges into a 
surface filament mediating the initial attachment to the target cells [80]. The VirB/VirD4 
T4SS has also been well-characterized in Bh and shown to transfer important 
Bartonella effector proteins (BepA through BepG) to host cells where they disrupt 
cellular functions favoring survival of the bacteria [81,82]. In vitro studies of human 
endothelial cells cultured with Bh showed that VirB/VirD4 T4SS along with the Beps 
mediate cellular changes such as a massive cytoskeletal rearrangement leading to the 
uptake of bacterial aggregates by a structure termed the “invasome” [54]. In addition, 
the VirB/VirD4 T4SS is required for NF-kB-dependent pro-inflammatory cytokine 
activation of IL-8 [83], expression of the cell adhesion molecules ((ICAM)-1 and E-
selectin) [71], and inhibition of endothelial cell apoptosis [80,83]. Recently, the role of 
some of the Beps was investigated by Scheidegger et al. using a 3D in vitro 
angiogenesis assay of collagen gel-embedded EC spheroids [84]. BepC, BepF and 
BepG were shown to promote invasome-mediated uptake of large Bh aggregates [84]. 
While BepG by itself was shown to exhibit an anti-angiogenic activity interfering with 
sprout formation, BepA was shown to induce sprouting of the endothelial spheroids 
similarly to sprouting triggered by VEGF [84].  
 
Trw type 4 secretion system 
The Trw T4SS is the other and the less studied T4SS found in Bartonella.  The 
VirB T4SS is required for the early infection stage and involved in establishing 
interaction of Bh with EC and in translocating effector proteins into the host cells [79,81], 
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whereas the Trw T4SS is involved in adherence and invasion of erythrocytes by 
surface-expressed T4SS pili and has not been shown to have the ability to transfer 
effectors into the host erythrocytes [82]. It has been suggested that the loss of flagella is 
correlated with the acquisition of Trw T4SS by the modern lineage species such as Bh, 
and the Trw system fulfills the erythrocyte adhesion role of the flagella among non-
flagellated Bartonella spp. [82]. The trw locus has multiple tandem gene duplications of 
trwL and trwJ-trwH which encode small adhesin-like proteins with varying copy numbers 
among Bartonella species [85]. The TrwJ and TrwL are the surface-exposed 
components that have been shown to specifically adhere to erythrocytes with TrwJ1 and 
TrwJ2 conferring host specificity for the bacteria [85-87]. 
 
Lipopolysaccharide (LPS) 
  LPS is a major component of the outer membrane of Gram-negative bacteria, 
and plays an important role in the pathogenicity of the bacteria. LPS induces a signaling 
cascade that leads to a NF-kB-dependent inflammatory response by binding to 
TLR4/TLR2, which interacts with accessory proteins CD14 and myeloid differentiation 2 
[88]. A pronounced immune response to LPS can lead to septic shock [89]. LPS of 
Bartonella has been shown to exhibit very low endotoxic activity, and this has been 
speculated to result in remarkable interaction and persistence of Bh in the endotoxin-
sensitive EC causing an angioproliferative phenotype rather than sepsis [90]. Bh LPS is 
structurally different than the typical LPS from E. coli [91], and evidence shows that 
purified Bh LPS did not stimulate TLR2 [92]. As reviewed by Harms and Dehio, 
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Bartonella LPS may have an immunomodulatory effect by acting antagonistically on 
TLR4 [48]. 
 
Other virulence factors 
Outer membrane proteins (OMPs) (28, 32, 43, 52, and 58 kDa) were described in 
Bh and shown to adhere to EC in vitro [93]. OMP43 was shown to bind fibronectin and 
human umbilical vein endothelial cells and might play a very important role in Bartonella 
infection [94,95]. It was demonstrated that Bh OMPs were sufficient to induce NF-
kB activation and expression of adhesion molecule followed by enhanced rolling 
and adhesion of leukocytes [71].  
 
1.4. Previous Bartonella infection models 
For over a decade, researchers have been looking into developing an animal 
model to study Bartonella infection and host response, but the efforts to establish such 
a model have met with limited success. Cats, the natural reservoir of Bh, when infected, 
do not exhibit symptoms such as lymphadenopathy and vasculoproliferation as seen in 
infected humans [96]. A primate rhesus macaque (Macaca mulatta) model was shown 
to reproduce characteristics of human infection with B. quintana [97], but use of this 
model system for Bh has not been reported. Moreover, attempts were made to infect 
C57BL/6 as well as BALB/c mice by inoculating 107 to 108 Bh cfu intraperitoneally or 
subcutaneously. However, both strains of mice were shown to clear the bacteria within 
days of inoculation with no increase in bacterial burden [98,99]. The mechanism by 
which the bacteria were cleared was not fully investigated. For those underlying 
14 
 
reasons, this research project aimed at investigating whether the zebrafish (Danio rerio) 
embryo model could be used to study Bh pathogenesis and response to infection. 
 
1.5. The zebrafish embryo model 
Overview  
Many invertebrate models including fruit fly (Drosophila) and the nematode 
worm, Caenorhabditis elegans, have been instrumental in helping investigate 
fundamental concepts in genetics and early development. Historically, mice have been 
the model of choice for developmental and genetic studies of vertebrates. However, 
there are several drawbacks: because fruit fly and C. elegans are invertebrates, they 
are evolutionarily divergent from humans and many key organs and the sophisticated 
immune system are absent in C. elegans [100]. Although mice are more closely related 
to humans, it is difficult to directly observe the cellular development because 
embryogenesis occurs in the uterus. In the early 1970’s, Dr. Georges Streisinger, a 
researcher at the University of Oregon, identified and developed the zebrafish as a 
model for genetic and developmental studies of vertebrates [101]. Since then the 
zebrafish has become a very popular model and used as a means to understand not 
only genetics and development of other fish but also as a means to study development 
in higher vertebrates. 
For decades the zebrafish embryo model has been an invaluable tool for genetic 
and developmental studies [102,103], but recently the use of zebrafish embryos has 
been extended to model pathogenesis in humans including bacterial infection and tumor 
angiogenesis, and to study drug discovery. The zebrafish embryo model has been used 
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to study infections with a number of Gram-positive as well as Gram-negative bacteria. 
For instance, zebrafish are susceptible to Streptococcus pyogenes, Pseudomonas 
aeruginosa, Staphylococcus aureus and Salmonella typhimurium [104-107]. 
Angiogenesis-inducing factor FGF-2 and mammalian tumor xenografts have been 
shown to induce neovascularization in the zebrafish embryo model [108-110]. More 
recently, the zebrafish embryo model has been applied to large scale drug screening 
and to detect off-target effects of drug candidates [111-113]. 
The zebrafish embryo model has increasingly attracted researchers for its utility 
in studying human diseases. Adult zebrafish reach sexual maturity at 3 to 4 months and 
a female can lay an average of 200 eggs a week for up to 4 years [114]. Zebrafish 
embryos are translucent during the first weeks post-fertilization making them suitable for 
microscopy allowing real-time analysis of bacterial infection [107]. Their ex-utero 
development allows access to embryos at all stages of development making post-
fertilization genetic manipulation of zebrafish embryos much easier. However, one of 
the most important characteristics is that they share similarities with the human immune 
system, having both innate and adaptive immune systems featuring the myeloid and 
lymphoid cells such as macrophages, neutrophils, dendritic cells, T cells and B cells 
[115-117]. 
 
1.6. Zebrafish innate immune system 
The innate immune system, which is composed of physical barriers, cellular and 
humoral components, is the first line of defense against infection. In the zebrafish 
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embryo, antimicrobial peptides, complement components and phagocytes are present 
within 24 hours post-fertilization (hpf) [115,116,118]. 
 
Cellular development and maturation 
In the zebrafish, hematopoiesis begins as early as 5 hpf producing three germ 
layers: ectoderm, mesoderm and endoderm [119]. Immune cell development occurs in 
waves of primitive and definitive hematopoiesis [120,121]. The primitive hematopoiesis 
starts in the anterior lateral plate, in which hemangioblasts differentiate into myeloid 
cells, and in the posterior lateral plate mesoderm which gives rise to erythrocytes [122]. 
The posterior lateral plate later develops and expands into the caudal hematopoietic 
tissue, a transitory site for erythroid and myeloid progenitor cells, from where they 
migrate to reside in the thymus and the pronephros, the definitive hematopoietic organs 
[122-124]. The pronephros develos into kidney marrow, which is the equivalent to  bone 
marrow in humans [115]. The final wave of definitive hematopoiesis occurs in the 
ventral wall of the dorsal aorta in which cells that have the ability to reconstitute all of 
the hematopoietic lineages are produced [125,126]. 
Macrophages are the first leukocytes in the zebrafish embryo to differentiate 
[127]. The ontogeny and behavior of early macrophages were studied by Herbomel et 
al. using video enhanced differential interference contrast (DIC) microscopy and in-situ 
hybridization for hematopoietic marker genes draculin and leukocytes-specific plastin 
[118]. As reported by Herbomel et al., macrophages migrate into the yolk sac as 
precursors cells where they differentiate just before the onset of blood circulation; many 
subsequently enter the blood circulation while others invade the mesenchyme of the 
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head, retina and epidermis [118]. At 30 hpf, macrophages are seen phagocytizing large 
amounts of bacteria soon after intravenous injection, and they can sense microbes 
injected though body cavities leading to their migration and killing of the microorganisms 
[118]. Although myeloperoxidase (mpx), a molecular marker for neutrophils, mRNA is 
detected as early as 28 hpf, the presence of mature neutrophils is not documented until 
48 hpf where they are seen in the trunk and tail of the zebrafish embryo [128-130]. 
Other myeloid cells that have been described in the zebrafish include mast cells, 
eosinophils and a population of dendritic-like antigen-presenting cells [117,131,132]. 
 
Transgenic reporter lines for live imaging 
Transgenic reporter lines expressing fluorescent proteins driven by leukocyte-
specific promoters are available to study the behavior of immune cells using live 
imaging. This technology helps in studying host-pathogen interactions in the zebrafish 
embryo model. Precursors of myeloid cells can be visualized using the spi1- or pu.-1 
GFP transgenic lines [130,133,134]. In addition to being used for vasculature system 
visualization, the Tg(fli1:EGFP)y1 transgenic line has been used to visualize early 
myeloid cells [135]. The mpx or mpo promoter is used in two transgenic lines to label 
neutrophil populations with bright GFP and an additional population of low GFP-
expressing inflammatory macrophages [136,137]. A macrophage-specific line has also 
been created using the promoter sequence of the mpeg1 gene [138]. 
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Pattern recognition receptors 
Like mammals and higher vertebrates, the zebrafish embryo expresses a broad 
range of germline-encoded pattern recognition receptors (PRRs) and adaptors. Those 
receptors are found on the surface, the endosomal compartments and in the cytosol of 
leukocytes including dendritic cells and macrophages recognizing evolutionarily 
conserved markers on pathogens called pathogen-associated molecular pattern 
(PAMPs) [139]. Some of the PAMPs expressed by zebrafish embryos include Toll-like 
receptors (TLRs) [140], NOD-like receptors (NLRs) [64,141], and C-type lectin receptors 
such as the complement activating mannose binding lectin (MBL) [142]. Upon the 
recognition of a PAMP, PRRs send signals to initiate pro-inflammatory and antimicrobial 
responses through different signaling cascades leading to production of pro-
inflammatory cytokines, chemokines and antimicrobial peptides [143]. 
 
Toll-like receptors 
TLRs are type I transmembrane proteins defined by the presence of an 
extracellular domain containing leucine-rich repeats (LRRs) and a cytoplasmic tail that 
contains a conserved region called the Toll/IL-1 receptor (TIR) domain that binds 
adaptor proteins such as  MYD88, Mal, TICAM-1, TRAM or SARM at the TIR domain to 
initiate signal transduction [144-148]. Following interaction with PAMPs, TLRs relay 
signals from the cell surface to the nucleus through adaptor molecules which share a 
common Toll/interleukine-1 receptor (TIR) domain with TLRs [116,145]. This process 
leads to MAP kinases family members’ activation, NF-kB translocation to the nucleus 
and ultimately the activation of inflammatory cytokines and chemokines, antimicrobial 
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mechanisms involving production of reactive oxygen and nitrogen species, and the 
triggering of the adaptive immune response [149]. 
The TLR family was first described in Drosophila and was shown to be implicated 
not only in immune defense but also in development [150,151]. In mammals and 
vertebrates, however, they are mainly involved in the innate immune system [152,153]. 
In the zebrafish, TLRs start to express shortly after gastrulation and over 22 putative 
variants of TLRs including orthologs of the human TLR families have been 
characterized [154,155]. In humans, TLR4 recognizes lipopolysaccharide (LPS) on the 
outer membrane of Gram-negative bacteria, TLR1 and TLR3 recognize lipoprotein and 
peptidoglycan from Gram-positive bacteria, TLR5 binds to bacterial flagella, and TLRs 
3, 7, 8, and 9 recognize viral nucleic acid during viral infection [156]. Most zebrafish 
TLRs share the same functionality with human TLRs, but because of genome 
duplication and alternative splicing zebrafish often have two forms of the TLRs [154]. 
For instance, zebrafish has two paralogs of TLR4 (TLR4a and TLR4b). However, as 
opposed to human, it was shown that LPS signaled through a TLR4- and MyD88-
independent manner in zebrafish, and that zebrafish TLR4a and TLR4b suppressed the 
MyD88-dependent NF-κB activation by sequestering the TLR adaptors [157,158]. 
 
Other pattern recognition receptors 
Other notable receptors described in the zebrafish antimicrobial immunity include 
nucleotide-binding-oligomerization-domain-(NOD-) like receptors (NLRs), RIG-I-like 
receptors (RLRs), scavenger receptors and C-type lectin receptors (CLRs). NLRs and 
RLRs are cytosolic PRRs that recognize intracellular pathogens that escape the 
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surveillance of the transmembrane PRRs [159]. Members of the NLR family (NOD1, 
NOD2) can recognize molecules on parasites and can detect the presence of bacteria 
through molecules produced during peptidoglycan synthesis or breakdown [160,161].  
Though the function of NLR family members has not been broadly studied in the 
zebrafish, typical members of the mammalian NLRs are conserved and play an 
antimicrobial role in zebrafish embryos [162,163]. Members of the RLRs family 
recognize viral RNA and when activated lead to production of type I interferon which 
binds to its receptor to initiate expression of IFN-stimulated genes [163]. Zebrafish 
homologs of some RLRs have been identified; however, analysis of their putative 
proteins showed that their domains distribution differed from those of human [163,164]. 
 Scavenger receptors are, on the other hand, cell surface family receptors that 
are not only present on immune cells namely macrophages, mast cells and dendritic 
cells, but they are also expressed by certain types of epithelial cells and endothelial 
cells [165,166]. They bind to a wide range of PAMPs which include LTA, LPS and CpG 
DNA [167]. Several homologs of the mammalian scavenger receptor family have been 
identified in the zebrafish genome; however, their functional identity remains elusive.  
For instance, the zebrafish macrophage receptor with collagenous structure (MARCO) 
gene, a specific marker for macrophages and dendritic cells, has been shown to play 
the same role in mammals as in zebrafish [167]. CLRs are soluble or membrane-
attached carbohydrate-binding proteins expressed by most cell types including 
macrophages and dendritic cells [168,169]. The mannose binding lectin (MBL) is a CLR 
protein that binds a wide array of sugar moieties found on fungi, protozoa, viruses and 
bacteria and activates the complement system [170]. MBL has also been identified in 
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zebrafish and was shown to be associated with complement activation and resistance to 
bacterial infection [171].  
  
Secreted proteins and peptide mediators of the innate immunity 
Zebrafish embryos express a variety of secreted proteins and peptide mediators 
such as cytokines, chemokines and antimicrobial peptides that not only control the 
innate immune system but also play an important role in the activation of the adaptive 
immune system in adult zebrafish. Homologs for many mammalian secreted proteins 
and peptide mediators of the innate immune response have been identified in the 
zebrafish embryo. 
 
Cytokines 
Cytokines are small proteins secreted by a broad range of nucleated cells 
including macrophages, neutrophils, B and T lymphocytes and endothelial cells, and 
have both autocrine and paracrine activities. The primary role of cytokines is to 
modulate the amplitude and direction of the immune responses [172]. There are two 
main groups of cytokines in inflammation: the pro-inflammatory cytokines which 
promote inflammatory responses and the anti-inflammatory cytokines which are 
involved in negative regulation of the inflammatory responses. The main pro-
inflammatory cytokines produced by zebrafish phagocytes include tumor necrosis factor 
(TNF), IL-1, IL-6, type I and type II IFNs, IL-22 and IL-26 [173-176]. In human, IL-10 is a 
strong anti-inflammatory cytokine and acts antagonistically to pro-inflammatory cytokine 
production by macrophage and T cells [177]. Zebrafish homologs IL-10 and its receptor, 
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IL-10R1, are identified and characterized, and are believed to play a similar role in the 
zebrafish immune response [178]. 
The importance of TNF signaling was studied in the zebrafish embryo infection 
model of the facultative intracellular bacterium Mycobacterium marinum. It was shown 
that TNF played a key role in controlling granuloma formation by inhibiting 
mycobacterial growth within macrophages and restricting their necrotic death [179]. 
mRNA expression levels of tnf and il1b genes were shown to increase in zebrafish 
embryos exposed to Edwardsiella tarda by static immersion as well as in adult zebrafish 
by injection [173]. Both pro-and anti-inflammatory cytokines were shown to be 
upregulated in zebrafish embryos in response to infection with Pseudomonas 
aeruginosa and Salmonella typhimurium [105,180]. The zebrafish homologs of the 
human IFNγ, IFN-γ1 and IFN-γ2, are required for resistance to bacterial infection in 
zebrafish embryos. The interferons were shown to be necessary to clear E. coli infection 
as well as Yersinia ruckeri, a natural fish pathogen that is lethal to the zebrafish 
embryos at low dose [181]. IFNθ and IFNθ2 are two groups of interferons in zebrafish 
that are closely related to human IFNs type I and type III, and shown to provide antiviral 
protection in a viral challenge assay [182,183].  
 
Chemokines 
Chemokines are specialized cytokines that direct the migration of cells involved 
in processes such as embryonic gastrulation and organogenesis, leukocyte trafficking, 
and immune surveillance [184]. Because of those important biological roles, 
chemokines have been viewed as key players in diseases involving infection, 
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inflammation and tumor [185]. Interleukin-8 (IL-8) or CXCL8 is the prototypical member 
of the CXC chemokines. This potent pro-inflammatory chemokine signals through 
CXCL1 and CXCL2, two G-protein coupled receptors that are known to bind 
chemokines other than IL-8 [186]. In addition to its chemotactic activity for neutrophils, 
basophils and monocytes, CXCL8 regulates the growth of endothelial cells by 
stimulating VEGF expression in an NF-kB-dependent manner [187]. Macrophage-
derived IL-8 signaling through CXCL2 has been shown to play a role in angiogenic-
dependent disorders such as tumor growth, rheumatoid arthritis, and wound healing 
[188].  
Zebrafish homologs of CXCL8 and its receptors have been sequenced and 
characterized, and their signaling pathway was shown to be conserved in the zebrafish 
embryo [185]. However, as opposed to its  mammalian counterpart, zebrafish CXCL8 
lacks the angiogenic ELR (Glu-Leu-Arg) motif that is known to play an important role in 
the recruitment of neutrophils in humans [189,190]. Nevertheless, the expression of 
zebrafish embryo IL-8 was shown to be upregulated in inflammatory conditions induced 
by bacterial or chemical stimuli and was shown to be crucial for normal neutrophil 
recruitment to the wound and normal resolution of inflammation [185,191].  
 
Complement components  
The complement system is an essential humoral system of innate immunity and 
links the innate immune response to the adaptive immune response. This system 
consists of over 35 secreted and membrane-bound proteins alerting the host of the 
presence of pathogens and killing those pathogens [192,193]. The complement system 
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can be activated through three different pathways: the classical pathway which is 
initiated by the binding of the C1 complex to antibodies bound to structures on the 
surface of the pathogen, the alternative pathway which is activated by the recognition of 
certain structures on the surface of the microbe in an antibody-independent manner; the 
lectin pathway which is triggered by the binding of polysaccharides to circulating lectins, 
such as mannose-binding lectin [194]. These pathways merge into a common 
amplification step involving C3, and continuing to the cytolytic pathway forming the 
membrane attack complex (MAC), which lyses the cell membrane and kills the microbes 
[195]. 
Zebrafish homologs of the fundamental complement components including C3, 
MBL, factor B (Fb) and factor H (Fh) have been identified [142,196-198]. The mRNA 
levels of c3 and bf in zebrafish embryo were shown to be significantly increased in 
response to LPS exposure [199]. This was further supported by evidence showing that 
cytosol prepared from newly fertilized eggs was able to kill E. coli [195]. The 
antibacterial activity of zebrafish egg cytosol was also attributed to the presence of 
lysozyme [200]. Moreover, many zebrafish complement components could be 
transferred from mother to eggs as evidence showed that immunization of adult female 
zebrafish with Aeromonas hydrophila resulted in an increase of C3 and Bf protein levels 
both in the mothers and early embryos [201]. 
 
Antimicrobial peptides 
Antimicrobial peptides are small cationic peptides of less than 100 amino acids 
that are an important component of the innate immunity, and are found in plants and 
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animals [202]. They have a wide bactericidal activity that includes killing of bacteria, 
viruses and fungi [203-205]. Small antimicrobial peptide genes such as defensins, 
hepcidin and phosvitin have been sequenced and characterized in the zebrafish embryo 
[206-209]. While some antimicrobial peptides are constitutively expressed and 
synthesized by cells such as keratinocytes, monocytes, neutrophils and epithelial cells, 
many are induced [209]. It was demonstrated that phosvitin played an important role in 
zebrafish embryos not only as an antimicrobial effector capable of killing microbes but 
also by acting as a pattern recognition receptor recognizing PAMPs of Gram-negative 
and Gram-positive bacteria [208]. Hepcidin gene expression was shown to be increased 
in fish that developed signs of bacterial infection [206].  
 
Antisense morpholino knockdown of innate immunity mediators 
 Morpholinos are the most commonly used tool to knockdown genes in the 
zebrafish embryo. While some morpholinos work by specifically binding near the 5’ UTR 
of the target RNA to block the access to the ribosomal initiation complex thus inhibiting 
protein translation, others work by blocking pre-mRNA splicing. In either case, the effect 
of morpholinos is most effective when injected at the 1- to 2- cell stage of the embryo; it 
results in a variable period (4 to 7 days) of transient knockdown of specific genes 
allowing researchers to study their role in zebrafish [210,211]. The role of MyD88, the 
most common adaptor for TLR signaling, in response to S. typhimurium infection in the 
zebrafish embryo was studied using a morpholino knockdown approach [180]. The 
induction levels of irak3, mmp9 and il-1b were shown to be significantly suppressed in 
the MyD88 morphants [180]. The Spi1/Pu.1 transcription factor is important for normal 
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development of the myeloid cell lineage, and morpholino knockdown of this gene results 
in embryos lacking macrophages and neutrophils [212]. Therefore, morpholino 
knockdown of this gene has often been used for infection studies in the zebrafish 
embryo model. These morphants showed increased susceptibility to infection with 
bacteria such as P. aeruginosa, E. coli and S. aureus [105,106,213,214] 
 
1.7. Zebrafish adaptive immune system 
While the zebrafish embryo has a fully mature innate immune system by 48 hpf, 
the adaptive immune system is not fully developed until 4- to 6- weeks post-fertilization 
[215]. However, B cell and T cell progenitors begin undergoing recombination activating 
gene (rag-)-dependent rearrangements within the kidney and the thymus, respectively, 
by 4 dpf [103]. Evidence for the existence of dendritic cells (DCs) and their function as 
professional antigen presenting cells (APCs) have been reported in the zebrafish 
[117,216]. As in humans, B cell and all T cell types, CD4+ T cells, CD8+ T cells and 
CD4+ CD25+ T regulator cells, have been described in zebrafish although their 
functional studies in the zebrafish are still lacking [217]. The adaptive immune response 
to infection initiates with APCs presenting processed foreign peptides derived from 
microbes to lymphocytes [217]. It is speculated that this process occurs primarily in the 
spleen, the secondary lymphoid organ of the zebrafish where DCs reside [117], and can 
also take place in the gut, where large numbers of DCs and  lymphocytes can be found 
[218,219].  
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1.8. Zebrafish vasculogenesis and angiogenesis 
The zebrafish circulatory system is as complex as that of mammals. Zebrafish 
vascular formation is composed of two main processes: vasculogenesis and 
angiogenesis. Like other vertebrates, zebrafish vasculogenesis involves the 
differentiation of lateral mesoderm to hemangioblasts which then differentiate into 
angioblasts and endothelial cells [112]. Angiogenesis, on the other hand, is the process 
through which new blood vessels are formed from existing vessels. It occurs during 
normal tissue growth and repair; it involves the activation and division of endothelial 
cells within an existing vessel inducing enzymatic activities that cause local breakdown 
of the vessel and the subsequent sprouting of new vessels [112]. The expression of 
hemangioblast markers such as the endothelium-specific receptor tyrosine kinase 
VEGFR2/Flk1 and the stem cell leukemia protein (SCL/Tal-1) have been detected in the 
lateral mesoderm of the zebrafish embryo by 12 hours post-fertilization [220,221]. By 24 
hpf, the zebrafish embryo develops a simple blood circulation loop in which the blood 
from the dorsal aorta and axial vein circulates through the yolk sac circulating valley 
prior to returning to the heart. Then by 72 hpf, a complete vascular system is formed 
containing the intersegment vessels (ISVs) of the trunk stemming from the dorsal aorta 
and the subintestinal vessels (SIVs), which are originated from the Duct of Cuvier 
through angiogenic processes [110]. 
Angiogenesis plays a critical role in tumor growth and metastasis and many 
genes that are involved in angiogenesis in higher vertebrates and mammals have also 
been identified in the zebrafish embryo. Among them are the VEGF and its tyrosine 
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kinase receptors (Flk-1 and Flt-1), and angiopoietin [222-224]. The vegf-A gene and its 
splicing isoforms, including the two dominant forms in vegf-A165 and vegf-A121, have 
been isolated and characterized in the zebrafish embryo [222,225]. The role of VEGF in 
vasculogenesis, angiogenesis, and hematopoiesis in the development of the zebrafish 
embryo has been studied. Liang et al. demonstrated that the overexpression of both 
isoforms resulted in early onset and increased transcript levels of endothelial cell 
markers (flk1, tie) and hematopoietic cell lineage markers (gata1, scl) [226]. Several 
studies show that overexpression of vegf leads to ectopic vasculature in the developing 
zebrafish embryo, which occurs via the interaction of VEGF with FLK1 and sydecan-2 
receptors [226-228]. Moreover, VEGF has been shown to be upregulated in 
pharmacologically induced vessel sprouting as well as pathologically induced 
angiogenesis in the zebrafish embryo [108,110,229-231].  
At least three homologs of mammalian angiopoietin genes (ang1, ang2, and 
angptl3), and the endothelium-specific tyrosine kinase receptors (tie1 and tie2) have 
been isolated in the zebrafish by Pham et al. and Lyons et al. [223,232]. Their 
transcripts were shown to be present in all EC of both developing and mature blood 
vessels. Furthermore, three angiopoietin-like proteins (angptl1, angptl2 and angptl6), 
homologous to human angiopoietin-like proteins, were isolated and characterized in the 
zebrafish embryo by Kubota et al. [233]. Contrary to angiopoietin signaling which occurs 
through Tie 1 or Tie 2 receptors, angiopoietin-like proteins do not interact with the Tie 
receptors. Another study by Kubota et al. has shown that cooperative interactions of 
Angptl1/2 play an important role in vascular development and angiogenesis [234]. They 
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were shown to bind endothelial cells displaying antiapoptotic activities via the PI3-K/Akt 
pathway in vitro [234]. 
Several vascular-specific transgenic lines of the zebrafish embryo including 
Tg(fli1:EGFP), VEGFR2-GFP, and Tie2-GFP have been developed. The 
Tg(fli1:EGFP)y1 strain, which expresses green fluorescent protein in the vasculature, 
has been used to model tumor angiogenesis using mammalian tumor xenografts as well 
as human metastatic melanoma cells [108,109]. Those reports and others showed 
evidence of tumor cell growth accompanied with the disruption of normal vessel pattern; 
sprouting of the vessels and tumor metastasis as seen in mammals [108,109,235].   
The angiogenic response in the zebrafish embryo model is often quantitatively 
assessed by measuring the size, the length and the branching of the blood vessels 
[110,236]. Moreover, quantitative real-time PCR (qRT-PCR) and ELISA methods to 
assess changes in gene expression in response to angiogenic stimuli are sometimes 
used to complement phenotypic observations in the zebrafish embryo model [237,238]. 
 
1.9. Objective  
Bh causes a wide range of infection in human, but it is known mostly for its 
unique ability to cause bacillary angiomatosis, a disease characterized by 
vasoproliferative tumor-like lesions in some immunosuppressed individuals. Over the 
past 15 years, Bartonella research has been advancing at a fast pace due in part to the 
availability of the complete genome sequence for Bh [73]. This has enabled the 
establishment of gene function and definition of important virulence factors associated 
with Bh-induced pathogenesis. Although much is known about Bh and those virulence 
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factors from studies using in vitro systems, their molecular mechanisms and overall 
contribution to Bh pathogenesis remains elusive and can only be fully understood by 
using an in vivo model. Therefore, there has been a great need for a practical animal 
model to study Bh pathogenesis and host response. To date, efforts to establish an in 
vivo model to study Bh pathogenesis have for the most part been unsuccessful. We 
proposed to use the zebrafish embryo to study Bh infection and host response. Based 
on our literature review and our preliminary data, we hypothesized that: the zebrafish 
embryo is a suitable model of transient infection with Bh requiring the action of 
the adhesin BadA and the type IV secretion system and is ultimately cleared by 
the innate immune response of the embryo. 
In order to test this hypothesis, the following objectives were developed and studied: 
1) Define the optimal conditions necessary to maintain the longest possible 
sustained infection of zebrafish embryos with Bh 
2) Examine the zebrafish response to Bh infection 
3) Determine if the trimeric autotransporter Bartonella  adhesin A (BadA) and the 
VirB/VirD4 T4SS are required in Bh infection in the zebrafish embryo in vivo 
model  
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Chapter 2 
Materials and Methods 
2.1. Bacterial strains and growth conditions 
The DsRed2 labeled kanamycin-resistant Bh strains were cultured on heart 
infusion agar (Remel, Thermal Fisher Scientific, Lenexa, KS) supplemented with 1% 
bovine hemoglobin (chocolate agar) (Remel, Thermo Fisher Scientific, Lenexa, KS) and 
50 µg/ml of kanamycin or in Schneider’s liquid medium (Sigma-Aldrich, St Louis, MO) 
supplemented with 10% fetal bovine serum and 50 µg/ml of kanamycin for 3-4 days at 
37ºC in the presence of 5% CO2 [239]. Escherichia coli (E. coli) strains were grown in 
Luria-Bertani (LB) broth or agar at 37ºC with no CO2. All manipulations of infectious 
agents in this project were approved by the USF Institutional Biosafety Committee.  
 
2.2. Animal care and strains 
Transgenic zebrafish embryos Tg(mpx:GFP)uwm1 were purchased from 
Zebrafish International Resource Center (Eugene Oregon). Adult breeders of the 
transgenic line Tg(fli1:egfp)y1 were a kind gift from Dr. Brandt Weinstein (NCI, Rockville, 
MD). Zebrafish breeders were maintained at 28 ± 0.5°C in a 14h:10h light/dark cycle in 
our breeding system designed by Aquatic Habitats (Apopka, FL) in accordance with 
standards established in the “Zebrafish Book” [240]. In the evening adult breeders were 
placed in a 1.5 ml breeding tank in a female to male ratio of 1:1 or 2:1 separated with a 
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divider. The next morning the divider was removed to allow mating and egg production. 
The eggs were collected and transferred to the laboratory where they were washed with 
0.065% of bleach in zebrafish embryo water and rinsed three times with fresh embryo 
water. After washing, the unfertilized eggs were discarded and the fertilized eggs were 
kept in fresh embryo water containing 2 µM of methylene blue at 30°C overnight. 
Methylene blue helps inhibit growth of fungi in the water.  Infected embryos were kept at 
30°C for a week post-fertilization. 
 
2.3. Ethics Statement 
This study was performed in strict accordance with the recommendations in the 
Guide for the Care and Use of Laboratory Animals of the National Institutes of Health.  
Zebrafish embryos and adults were maintained in accordance with standards 
established in the “Zebrafish Book” [240], and by the guidelines outlined by the 
Institutional Animal Care and Use Committee (IACUC) at the University of South 
Florida. The experiments using zebrafish embryos described in this report were 
approved by the USF IACUC under protocol R4174. 
 
2.4. Construction of Bh knockout mutants 
Bh genomic DNA extraction 
Bh genomic DNA was prepared using our standard laboratory protocol to extract 
genomic DNA from Bh. One quarter to half plate of 3 to 4 day growth bacteria was 
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harvested in 400 ml of  1x Tris EDTA (TE) buffer (pH 7.5), and the bacteria were lysed 
in a 1% final concentration of sarkosyl and 100 µg/ml final concentration of proteinase K 
for 90 minutes at 55°C. After cooling down to room temperature (RT), the sample was 
extracted through a series of steps of phenol/chloroform treatment and centrifugation at 
16,000 x g for 3 minutes using an Eppendorf Centrifuge (USA) – the sample was 
treated with 1 volume of saturated phenol (pH 6.6) twice followed by chloroform 
(chloroform/isoamyl alcohol 24:1) treatment 2 to 4 times or until the top layer which 
contained the DNA was clear, which then followed by a final chloroform 
(chloroform/isoamyl alcohol 24:1) extraction. The DNA was then precipitated in 0.1 
volume of 3 M NaOAc and 2.5 volume of absolute ethanol (EtOH) overnight at -20°C. 
The precipitate was spun down for 30 minutes at 16,000 x g at 4°C and the supernatant 
was discarded. The pellet was rinsed with cold 70% EtOH and spun at 16,000 x g for 5 
minutes. The supernatant was discarded and pellet was dried in a Speed Vac SC100 
(Savant Instrument, Inc., Hicksville, N.Y.) for 10 minutes. The DNA was then 
resuspended in 30 µl of TE/RNAse (0.2 mg/ml of RNAse). Note that the TE/RNAse 
solution was heated at 80°C for 20 minutes to inactivate any contaminating DNAse. 
 
Preparation of plasmid DNA from E. coli 
E. coli was inoculated in LB broth and grown overnight at 37°C with shaking at 
220 RPM. Plasmid DNA extraction was prepared using the Pure Yield Plasmid Midi 
Prep System according to the manufacturer’s instruction (Promega, Madison, WI). 
Briefly, overnight culture was pelleted by centrifugation at 5000 x g for 10 minutes. The 
pellet was resuspended in Cell Resuspension Solution and an equal volume of Cell 
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Lysis Solution was added. The mixture was inverted 3 to 5 times and incubated for 3 
minutes at RT. Neutralizing Solution was added to neutralize the lysis solution by 
inverting the sample and incubating for 3 minutes to allow proteins and cellular debris 
precipitation. The sample was then purified using a Pure yield Cleaning Column and 
centrifugation at 1500 x g for 5 minutes to separate the solution containing the DNA 
from the debris. The sample was then added to a Pure Yield Binding Column and spun 
at 1500 x g for 3 minutes to bind the DNA to the column. The column was washed with 
Endotoxin Removal Wash Solution containing isopropanol. The sample was spun at 
1500 x g for 3 minutes and the column was washed again with Column Wash Solution 
containing EtOH and was spun as before followed by centrifugation at 1500 x g for 10 
minutes to ensure that residual EtOH was removed. To elute the DNA, the column was 
placed in a new tube, followed by the addition of nuclease-free water and centrifugation 
at 2000 x g for 5 minutes. 
In-frame deletion mutants of the full length badA (BH01510) and the virB operon 
(virB2-virB11) were constructed in Bh Houston-1 using the two-step mutagenesis 
strategy described by Mackichan et al. with some modifications [241]. Bh genomic DNA 
was used as template for PCR to generate two fragments of the gene. The first 
fragment contained an upstream noncoding region and included a small segment of the 
5’ part of the gene whereas the second fragment contained a downstream region and a 
3’ segment of the gene. The two purified PCR products were used as templates for 
megaprime PCR using only the forward primer from fragment 1 and the reverse primer 
from fragment 2. The resulting product was purified and ligated into the “suicide” 
plasmid pJM05 at the BamHI restriction site.  
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The plasmids containing the deleted gene were transformed into DH12S E. coli 
(Life Technologies) and then incorporated into Bh Houston-1 by transconjugation using 
a two-step allelic exchange strategy [241]. The pJM05 derivative integrated into the Bh 
chromosome by homologous recombination with the sequences flanking the target 
gene. Transconjugates were selected by plating on 5% rabbit blood agar supplemented 
with kanamycin (30µg/ml), nalidixic acid (20µg/ml), and cefalozin (2µg/ml). The colonies 
were then counter-selected on agar containing 10% sucrose to promote excision of the 
integrated plasmid by a second cross-over event resulting in replacement of the full 
length gene with the truncated version. PCR was performed on genomic DNA isolated 
from kanamycin-sensitive sucrose-resistant colonies to confirm the knockout genotype. 
The deletion mutants were verified by sequencing across the deleted region and by 
performing RT-PCR to ensure the absence of the mRNA from the mutants.  
 
2.5. Construction of red fluorescent protein expressing strains of Bh 
The plasmid vector pDsRed2 (Clonetech, Mountain View, CA) was used as a 
template to amplify the Discosoma sp. dsred2 gene for cloning into pNS2T5 vector 
containing a kanamycin resistance gene [242]. The amplicon was digested with BamHI 
and XbaI (New England Biolabs) and then ligated into similarly digested pNS2T5 such 
that the dsred2 gene was expressed as a 6xHis tagged fusion protein. The resulting 
plasmid, pNS2T5-DsRed2, was electroporated into Bh Houston-1 wild-type, ΔbadA, and 
ΔvirB mutants making red fluorescent protein (RFP)-expressing strains 
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Bh/pNS2T5DsRed2, BhΔbadA/pNS2T5DsRed2, and BhvirB/pNS2T5DsRed2, 
respectively.  
A chromosome knock in strain of Bh Houston-1 expressing DsRed2 
(Bh::DsRed2) was constructed by cloning of the T5 promoter-dsred2 into the 
multicloning site (MCS) of EZ-Tn5 pMOD-6<Kan-2/MCS> transposon construction 
vector (EPICENTRE, Madison, WI). The KanT5 DsRed transposon DNA was amplified 
by PCR and purified using the Wizard SV Gel and PCR Clean-up System according to 
the manufacturer’s instructions (Promega). The stable transposome was prepared with 
the transposon DNA and the transposase enzyme according to manufacturers’ protocol 
and electroporated into Bh Houston-1. After kanamycin selection, transposon knock in 
strains were identified by confocal microscopy as those expressing RFP. Further, the 
clones were subjected to inverse PCR and sequencing methodology to confirm that the 
DsRed2 transposon was not inserted into an important gene. It was determined that the 
knock-in strain selected for further use had the transposon introduced in the intergenic 
region upstream of the hypothetical protein BH14030 and downstream of BH14040. 
Growth curve experiments showed no difference in growth between the chromosomally 
inserted DsRed2 or the plasmid encoded DsRed2 Bh Houston-1 strains when 
compared to WT Bh (data not shown).  
 
2.6. Zebrafish embryo staging and microinjection 
Before microinjection, embryos were staged at 24-28 hours post-fertilization (hpf) 
and manually dechorionated using two pulled-glass needles under a dissecting scope 
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(Nikon). Embryos were anesthetized in 0.02% tricaine methanesulfonate (Sigma) in 
embryo water [240]. Microinjection needles were pulled from 1.0-mm borosilicate glass 
micropipette using the PC-10 vertical puller (Narishige). 
Bh and E. coli cultures were pelleted by centrifugation at 3000 x g for 5 min and 
resuspended in 0.05% phenol red in phosphate-buffered saline (PBS; pH=7.4) to help 
monitor the microinjected solution. The suspension was serially diluted and plated to 
determine the number of colony forming units (CFUs) indicating the number of viable 
bacteria. All Bh plates were incubated at 37°C with 5% CO2 for 10 days; E. coli bacteria 
were plated on LB agar and incubated overnight at 37°C. For microinjection, 
anesthetized embryos were placed into a holding groove in 3% agarose to immobilize 
them for microinjection. Embryos were microinjected in the yolk sac or the blood 
circulation using thin pulled-glass needles attached to a Kite micromanipulator (WPI, 
Sarasota, Florida), a PV830 pneumatic pump microinjector (WPI, Sarasota, Florida), 
and a SMZ 1500 dissecting microscope (Nikon). To determine the infection doses, 
bacterial suspensions were expelled into microcentrifuge tubes containing 1X PBS 
before, during and after microinjection and plated for CFU enumeration or saved for 
qPCR experiments. For angiogenic response experiments, positive control embryos 
were injected with 10 ng of recombinant zebrafish VEGF (rzfVEGF) (R&D Systems; 
Minneapolis, MN). 
2.7. Digital imaging and microscopy of zebrafish embryos 
To monitor bacterial infection and host interaction in real time, embryos from the 
experimental and control groups were anesthetized and suspended in a depression 
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slide in 0.05% agarose/embryo water. Live embryos were examined with a 20x LUC 
Plan FLN 0.45 N.A. objective using an Olympus FV1000 confocal laser scanning 
microscope (Olympus America, Center Valley, PA). EGFP-vasculature of the embryo 
and DsRed2-expressing bacteria were imaged by a 488 nm laser with 475-519 nm 
spectral emission setting and a 543 nm laser with 525-615 nm emission, respectively. 
For time-lapse imaging, live embryos were viewed with a 20x UPLSAPO 0.75 NA, WD 
0.65mm objective using an Olympus IX81 inverted microscope equipped with the 3i 
Yokogawa spinning disk scanner and CDD cameras. Some pictures were viewed using 
the FluorView 10-ASW 1.7 and analyzed by using the NIH ImageJ software. Others 
were analyzed using the SlideBook 5.5 software and the SMRecorder software to make 
3D surface view videos showing the interaction of the RFP-expressing bacteria and the 
GFP-expressing endothelial cells. Adobe Photoshop CS5.1 software was subsequently 
used to arrange and format the images and all micrographs were reported as projected 
z-series. 
 
2.8. Bacterial enumeration from zebrafish embryos 
Bh infection and viability in the zebrafish embryo host were determined at 
different time-points after infection. Three to five embryos from of the infected and 
control groups were washed 3 times with 1X PBS and transferred to 1.5 ml tubes. 
Whole embryo tissues were disrupted in 0.1% saponin/PBS solution using sterile 
disposable plastic pestles. The suspension was serially diluted and plated on chocolate 
agar plates containing 50 μg/ml of kanamycin. The plates were incubated at 37°C with 
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5% CO2 for 10 days to determine number of CFUs. The means of triplicate samples 
were used for comparison between experimental and control groups at different time 
points. 
 
2.9. Genomic DNA extraction and qPCR 
Infected and control zebrafish embryos were individually stored at -80°C at 
different time points for genomic DNA extraction. Embryos were homogenized 
individually and total DNA was extracted using the Wizard Genomic DNA Purification Kit 
(Promega) according to the manufacturer’s instructions for extracting genomic DNA 
from animal tissue and Gram-negative bacteria with slight modifications. Before the last 
isopropanol precipitation step, 5 μg of glycogen was added to help precipitate the 
nucleic acid. The final DNA pellet was resuspended in 20 µl of TE. To construct a 
standard curve, known amounts of Bh genomic DNA purified by the same procedure 
were utilized as template for qPCR. The genome equivalent (GE) per microliter/template 
was calculated by dividing the concentration (g/µl) of the extracted DNA by the 
molecular weight of the Bh genome (2.08 x 10-15 g/copy). The bacterial nucleic acid was 
serially diluted to generate standards facilitating conversion of real-time PCR cycle 
threshold values to Bh NADH dehydrogenase gamma subunit G gene (nuoG) 
(BH08890) copies per embryo. Quantitative polymerase reactions (qPCR) were run in 
25 μl volume reactions containing 12.5 μl of 2X iQSYBR Green Supermix, 300 nmol of 
each primer, and 5μl of extracted DNA using the cycling parameters as follows: 95°C for 
3 min, followed by 40 cycles of 60°C for 30s and 55°C for 1 min. The primer sequences 
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for qPCR were as follows: nuoG forward 5’-GGCGTGATTGTTCTCGTTA-3’; nuoG 
reverse 5’- CACGACCACGGCTATCAAT-3’ [243]. A melting curve analysis was 
performed to confirm that no primer-dimers were amplified. All samples were run in 
triplicate, and the average GE for 5 embryos was calculated.  
 
2.10. Antibacterial activity 
In order to induce the production of antimicrobial factors, zebrafish embryos were 
staged at 28 hpf and inoculated in the yolk sac with Bh. Pools of 20 embryos were 
saved at -70°C at day 4 post-inoculation and homogenized with a pellet pestle. The 
lysate was spun down at 3500 x g for 5 minutes at 4°C to remove the debris. The 
supernatant was collected into a 1.5 ml tube and filtered through a pre-wetted 0.45μm 
filter to remove any bacterial contaminant including Bh. HMEC cells were also 
harvested to use as a control. HMEC cells were cultured without antibiotics in a flask 
and washed 5 times with 1X PBS to remove growth supplements. HMEC lysates were 
sonicated using a Sonic Dismembrator 120 (Fisher Scientific) for two minutes in 15 
seconds interval at 30% setting on ice. The lysate was processed as was done for 
zebrafish lysate. The filtered supernatants were then transferred into YM-3 centricons 
(Millipore, USA) and spun at 4,000 x g for up to 40 minutes at 4°C to concentrate the 
protein. YM-3 centricons have a 3,000 nominal molecular weight limit (NMWL) cut-off, 
which allows the retention of small antimicrobial peptides. The amount of protein in the 
lysate was calculated by a BCA protein assay. Bh culture was prepared in Schneider’s 
medium and seeded into 3 sets of triplicate wells in a 96-well plate. Embryo lysates 
were added into one set of triplicate wells as the experimental group, HMEC lysates 
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were added into another set of triplicate wells and 1x sterile PBS was added into the 
last set of triplicate wells. The 96 well-plate was sealed and incubated at 30°C for up to 
5 days.  
 
2.11. RNA isolation 
Pools of 10 embryos were stored at -80°C for RNA extraction and purification as 
described by Leung et al. [244]. Briefly, frozen embryos were homogenized with Trizol 
Reagent (Invitrogen, Grand Island, NY) using an RNAse-free Kontes pellet pestle 
(Fisher Scientific, Pittsburg, PA). The samples were spun at 21,000 x g for 2 minutes in 
a QIAshredder column (Qiagen, Valencia, CA) for further homogenization. 
Subsequently, total RNA was extracted twice with chloroform (chloroform/isoamyl 24:1) 
in Heavy Phage Lock Gel tubes (Fisher Scientific, Pittsburg, PA) to separate the 
aqueous phase from the organic phase. The extracted RNA was then purified using the 
RNeasy MinElute Cleanup kit (Qiagen, Valencia, CA) according to the manufacturer’s 
instructions. The RNA was eluted using diethylpyrocarbonate (DEPC)-treated water. 
The RNA was subsequently treated with Turbo DNAse (Ambion) according to the 
manufacturer’s protocol. The yield and the integrity of the extracted total RNA was 
evaluated by measuring the ultraviolet (UV) absorbance using the ND-1000 nanodrop 
spectrophotometer (Thermo Scientific, Wilmington, DE) and by agarose gel 
electrophoresis. 
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2.12. Microarray 
The microarray experiments and data analysis were performed in the Moffitt 
Cancer Center and Research Institute Molecular Genomics Core Facility. RNA from 
pools of Bh-infected and control embryos was isolated as described above.  The 
resulting RNA (100 ng) was used as a template to generate amplified complementary 
DNA (cDNA) via a three-step process called Ribo-SPIA™ using the Ovation® Pico WTA 
System V2 kit and the WT-Ovation® Exon Module according to the manufacturer’s 
instructions (NuGEN Technologies, San Carlos, CA) and as described by Clement-Ziza 
et al. [245]. The hybridization mixture was prepared to accommodate 5 µg of cDNA 
target. The Zebrafish Gene 1.0 ST Arrays were hybridized, washed, and stained 
according to the Affymetrix protocol. The arrays were scanned using a GCS3000 7G 
scanner (Affymetrix) and images (DAT files) were converted to CEL files using AGCC 
software (Affymetrix). Robust Multi-array Average (RMA) data analysis was performed 
using expression console V1.2 Affymetrix. Differential gene expression analysis was 
performed using Excel.  
 
2.13. cDNA synthesis and qRT-PCR 
The DNAse-treated RNA (1 µg) was reverse transcribed into cDNA in a 20 µl 
reaction using the iScript cDNA Synthesis Kit (Bio-RAD). Real-time PCR was performed 
using the iCycler IQ real-time PCR detection system (Bio-Rad). Each reaction was 
performed in a 25 μl volume containing 2 µl (100 ng) of cDNA, 12.5 μl of 2X iQSYBR 
Green Supermix (Bio-Rad) and 300 nmol of each primer. All reactions were performed 
in triplicate, and zebrafish elongation factor -1 (elf1α) or ribosomal protein L13 (rpl13) 
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was used as endogenous gene for normalization. Cycling parameters were 95°C for 3 
min, followed by 40 cycles of 60°C for 30s and 55°C for 1 min. Melting curve analysis 
was performed to confirm that no primer dimers were amplified. Results were analyzed 
using the comparative CT method (2-∆∆Ct) [246]. 
 
2.14. Statistical analysis 
The SigmaPlot 11.0 software was used to graph and statistically analyze the 
data. One Way Repeated Measures of Analysis of Variance (One Way Repeated 
ANOVA) test was used to assess the significance in the increase in bacterial burden at 
different time points post-infection. Student’s t-test was used to determine the 
significance of the angiogenic phenotype difference in the mean values of the 
intersection points (IPs: are the intersections where the subintestinal vessels branch 
out) and the number and length of the subintestinal vessel among the infected and the 
control groups. The Mann Whitney Rank-Sum Test was used to analyze the difference 
in the infectivity of Bh WT compared to the ΔbadA mutant at the different time points. 
The error bars represent the standard error of the mean.  
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Chapter 3 
Results 
3.1. Zebrafish embryo–site of injection with Bh and incubation condition 
In most zebrafish infectious disease models, infection is achieved by 
microinjecting the microbe into the embryo. However, zebrafish infection by immersion 
has been achieved by some natural fish pathogens as is the case for Edwardsiella tarda  
[173]. We attempted to infect dechorionated zebrafish embryos at 24 hours post- 
ertilization (hpf) by static immersion for 16 hours with 108 CFU/ml of Bh Houston-1 (WT) 
carrying a plasmid expressing red fluorescent protein (Bh/pNS2T5DsRed2). Results 
from confocal microscopy and colony forming unit (CFU) counts from homogenate 
plating of embryos were negative for Bh (data not shown). Therefore, we used a 
microinjection technique as the means of introducing the bacteria into the embryos. 
Since zebrafish optimal temperature is 28.5°C and Bh are exposed to 37°C in the 
human host, we assessed the infection pattern in infected embryos kept at constant 
temperatures of 28.5°C versus those that are kept at 30°C or 33°C. No significant 
difference in infection pattern was observed, and the proper development of the 
embryos did not seem to be compromised (data not shown). For all subsequent 
experiments, embryos were kept at 30°C to allow for both sufficient bacterial growth and 
to maintain the health of the embryos. 
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For most bacteria studied using the zebrafish embryo model, infection is 
achieved by microinjection via different sites depending on the type of experiment being 
performed. Microbes can be injected in the yolk sac, the posterior blood island or the 
Duct of Cuvier (yolk sac circulating valley) to initiate systemic infection, whereas a local 
infection can be achieved by injecting the microbes into the hindbrain, the tail muscle, or 
the otic vesicle (Fig. 3.1A) [107,118,130,247,248]. In an effort to determine the optimal 
infection route, Tg(fli1:egfp)y1 transgenic embryos were staged at 28 hpf and 
microinjected either in the yolk sac or the blood circulation valley with approximately 3 x 
103 CFU of Bh Houston-1 (WT) expressing red fluorescent protein from a single 
transposome inserted into the chromosome (Bh::DsRed2). Bacteria injected in the blood 
circulation were cleared by day 2 post-injection (dpi) as shown by the DsRed2 signal, 
whereas those inoculated in the yolk sac near the developing subintestinal vessels 
replicated and persisted throughout the duration of the experiment (3 dpi) (Fig. 3.1B). 
 
 
 
 
 
 
 
 
Figure 3.1 Zebrafish embryo injection site with Bh. A). Schematic representation 
of the zebrafish embryo at approximately 48 hpf highlighting the possible sites of 
injection (not drawn to scale). B) Representative micrographs of embryos inoculated 
in the yolk sac circulation valley (row 1) or the yolk sac (row 2) at 28 hpf with an 
average of 3 x 103 CFU Bh::DsRed2. The same embryos were photographed by 
confocal microscopy at the indicated time points. Scale bar = 100 µm. 
A 
B 
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3.2. Bh infection and survival in the zebrafish embryo host 
In order to assess Bh infection and viability in the zebrafish embryo host, 
Tg(fli1:egfp)y1 transgenic embryos were staged at 28 hpf and microinjected in the yolk 
sac near the developing subintestinal vessels with 3 x 103 genomic equivalents (GEs) of 
Bh::DsRed2. Microscopy results showed an increase in bacterial burden with peak 
fluorescence observed on day 3 post-infection (dpi) and persistence through the entire 
duration of the experiment (6 dpi) (Fig. 3.2). 
 
 
 
 
 
 
 
 
 
 
 To determine the viability of the bacteria in the host, embryos were inoculated 
with approximately 5 x 103 CFUs or PBS phenol red control, and three embryos were 
homogenized individually and plated in triplicate on selective kanamycin chocolate agar 
plates (50 µg/ml) at different time points post-infection for bacterial enumeration. 
Results showed an increase in CFU count which peaked at 3 dpi and started 
decreasing at 4 dpi (Fig. 3.3A). An alternative qPCR method using primers specific to 
 
Figure 3.2. Live imaging of zebrafish embryos infected with Bh. Confocal 
imaging of embryos inoculated with 3 x 103 GEs of Bh::DsRed2 (row 1) or PBS 
phenol red control (row 2) by microinjection into the yolk sac. All images shown 
are representatives of the pool of embryos photographed. Scale bar = 100 µm. 
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the Bh NADH dehydrogenase subunit G gene (nuoG, BH08890) was used to determine 
GEs/embryo. Embryos microinjected at 28 hpf with approximately 3 x 103 GEs of Bh 
were homogenized; the bacterial nucleic acid was extracted and the GE/embryo was 
determined by qPCR. Embryos mirrored the infection pattern observed by confocal 
microscopy and plating with bacterial burden increased by almost 10-fold by day 3 (*p = 
0.02) and persisted in the embryos for 8 days (Fig. 3.3B). The limit of detection of the 
assay was approximately 10 copies of nuoG per reaction and the sequence was not 
amplified from the uninfected control embryos (data not shown). 
 
 
 
 
 
 
 
 
 
 
 
 
3.3. Bh interaction with zebrafish embryo vascular endothelium 
Tissue samples from patients with BA lesions revealed the presence of immature 
capillaries that are lined with inflamed endothelium and filled with bacterial aggregates 
  
Figure 3.3. Bh infection and survival in the zebrafish embryo host (A) Average 
CFUs (± SEM) from homogenate plating of embryos inoculated with approximately 5 
x 103 CFUs of Bh. (B) Average GE/embryo determined by qPCR in embryos 
inoculated at 28 hpf with approximately 3 x 103 GEs of Bh. Values are the means (± 
SEM) of triplicate wells for 5 different embryos at the indicated time points. 
Significant increase in bacteria burden was observed from day 0 to day 2 with **p = 
0.013, from day 0 to day 3 with *p = 0.02 and from day 0 to day 4 with ***p = 0.002. 
As expected the nuoG sequence was not amplified from uninfected control embryos.  
 
A B 
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[60,61]. Therefore, the location of the bacteria, or bacterial aggregates, in relationship to 
the vascular endothelial cells in infected Tg(fli1:egfp)y1 embryos was determined by 
confocal microcopy (Fig. 3.4). Microscopy evidence showed that some of the red 
fluorescent Bh were colocalized with the green fluorescent angioblasts, the precursor of 
vascular endothelial cells, at day 1 post-infection (Fig. 3.4B), and with the mature 
vascular endothelium at day 2 post-infection (Fig. 3.4C) as shown by the arrows in inset 
images S1 and S2 at the respective time points. However, subsequent analysis was 
necessary to ascertain whether the bacteria were located either inside or merely 
interacting with the host cells. The SlideBook 5.5 software was used for three-
dimensional analysis of the micrographs and videos were made using the SMRecorder 
software. Analysis showed that aggregates of bacteria were interacting with the EC; 
some were inside of the cells while most were located outside or away from the 
endothelium (data not shown). 
 
3.4. Recruitment and accumulation of phagocytes to the site of infection with Bh  
Bh-induced angiogenic lesions in HIV patients have been shown to be infiltrated 
with phagocytes [60,61]. To investigate if Bh could recruit phagocytes to the site of 
infection, we injected Bh::DsRed2 in the yolk sac of Tg(mpx:GFP)uwm1 embryos at 50 
hpf, a transgenic zebrafish line that expresses GFP under the neutrophil-specific 
myeloperoxidase promoter [235]. Upon microscopic examination of live, infected 
embryos using the Olympus IX81 inverted microscope equipped with the 3i Yokogawa 
spinning disk scanner and CDD cameras, we observed that the infection induced the 
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accumulation and colocalization of neutrophils (bright green) with the bacteria (red) at 
the site of infection within 2 hpi (Fig. 3.5; top panel). The number of phagocytic cells 
increased during the course of infection as shown by the increase in neutrophils (bright 
green) (Fig. 3.5; arrow; top panel) and what we presumed to be macrophages (larger, 
light green) (Fig. 3.5, arrowhead; top panel) at day 4 post infection in the infected 
embryos. Time-lapse imaging further confirmed our observation with the slow moving 
macrophages (data not shown). Macrophages have previously been observed by 24 hpf 
in zebrafish embryos based on morphology and phagocytic capacity [118,213,248]. As 
observed in the videos, some bacteria were engulfed by the neutrophils and 
macrophages; however, most of the bacteria were seen outside of the phagocytic cells. 
Compared to the infected embryos the sham injected control embryos did not show as 
many phagocytes in the yolk sac (Fig. 3.5; 2 hpi and 4 dpi; bottom panels). 
 
 
 
 
 
 
 
 
 
Figure 3.4. Interaction of Bh with GFP-labeled endothelial cells in 
Tg(fli1:egfp)y1 zebrafish embryo. (A) Non-infected control embryo at day 1 post 
inoculation with PBS/phenol red. (B) and (C) Micrographs of embryos at day 1 and 
day 2 post-inoculation, respectively. Insets S1 (scale grid = 50 µm) and S2 (scale 
grid = 10 µm) are higher magnification images of the selected area of Bh and EC 
interaction. Arrows show areas of adherence and intracellular location of the RFP-
labeled bacteria with GFP-labeled EC of the vessels. Images are representatives 
of pools of embryos micrographed. Scale bar = 50 µm. 
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3.5. Antibacterial activity in zebrafish embryo extract 
In an effort to determine if zebrafish embryo extracts possess bactericidal activity 
against Bh, extracts from pools of embryos that were primed with Bh were prepared 
after 4 days post-inoculation. This time point was chosen due to evidence showing that 
the bacteria burden peaked at 3 dpi and started reducing on day 4 or 5 post-infection in 
the embryos. HMEC lysate was used as a control. The lysates were filtered and the 
amount of protein was quantified by BCA protein assay. The lysates were plated to 
ascertain that they were free from bacterial contamination including Bh. An average of 
 
Figure 3.5. Infiltration and colocalization of GFP-labeled phagocytes with Bh. 
Representative micrographs from pools of Tg(mpx:EGFP)umw1 embryos inoculated 
at 50 hpf with 300 CFU of Bh WT (top panel) or PBS/phenol red control (bottom 
panel) at the indicated time points post inoculation. White arrows are DsRed2 Bh 
colocalized with GFP-labeled neutrophils (bright green; 2 hpi and 4 dpi)). Arrowheads 
are DsRed2 Bh interacting with macrophages (larger phagocytes) (4 dpi only). 
Compared to the infected embryos, minimal numbers of GFP-labeled phagocytes are 
observed in the non-infected embryos (2 hpi; 4 dpi). Scale bar = 50 µm. 
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7.5 x 102 CFU/ml of Bh were co-inoculated with a final concentration of 138 µg/ml of 
embryo protein in Schneider’s medium in a 96-well plate. The culture was plated at time 
points 0 hr, 3 and 5 days post-exposure to the lysates for CFU count and percent of 
bacteria growth inhibition. The data showed that crude embryo lysates did not inhibit the 
growth of Bh in vitro; in fact it promoted the replication of the bacteria (Fig. 3.6). 
Compared to the PBS control at day 3 post-exposure, the HMEC lysate and the embryo 
lysate increased the growth of Bh by 80 and 10,000 fold, respectively. At day 5 post-
exposure, HMEC increased bacterial survival by 1,875 fold and embryo lysate 
increased the bacterial survival by 2,562 fold. This might be due to the presence of 
nutrients in the embryo extracts that could help sustain bacterial survival.  
 
 
 
 
 
 
 
 
 
 
Figure 3.6. Bh exposed to crude zebrafish extracts increase bacterial 
growth. 7.5 x 102 CFU/ml (± SEM) of Bh was co-incubated with zebrafish lysate, 
HMEC lysate or 1 x PBS for 5 days post-incubation. Representative graph 
showing Bh exposure to zebrafish embryo lysates and HMEC lysates. 
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3.6. Angiogenic phenotype and inflammatory and angiogenic responses in Bh 
infected embryos 
In order to evaluate the angiogenic effect induced by Bh infection, Tg(fli1:egfp)y1 
transgenic embryos were inoculated with an average of 3 x 103 GEs of Bh::DsRed2. 
Confocal laser scanning microscopy was used to examine the embryos and evaluate 
blood vessel formation and morphology near the site of infection. Infected embryos 
were analyzed for vessel sprouting at 48 hpi (Fig. 3.7). Note that the red fluorescent 
overlay showing the RFP bacteria in the infected panel (ii) was omitted to help better 
visualize the subintestinal basket (the branching network of blood vessels within the 
yolk sac), so the inset image represents the same embryo showing the bacteria at the 
site of infection. Compared to the uninfected control group (Fig. 3.7A, i) and the 
rzfVEGF-injected control group (Fig. 3.7A, iii), blood vessel sprouting, shown by the 
white arrows, could be seen at the subintestinal basket of the infected embryos (Fig. 
3.7A, ii). The length of the SIVs was measured and the evidence showed a lengthening 
of the SIVs in the infected samples compared to the controls (Fig. 3.7B).  
Moreover, the phenotypic changes induced by Bh infection in the transgenic 
embryos infected with Bh/pNS2T5DsRed2 from an independent experiment were 
assessed at day 4 post-infection (Fig. 3.8); the inset image showed the presence of the 
red fluorescent bacteria at the site of infection. A larger subintestinal basket was 
observed in the infected embryos (Fig. 3.8A, ii, white oval) compared to the non-
infected control embryos (Fig. 3.8A, i) and similar to the positive control injected with 
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rzfVEGF (Fig. 3.8A, iii), suggesting that the bacteria triggered an angiogenic response 
that affected the pattern of the subintestinal vessels (SIVs: vessels located in the oval) 
at the site of infection. This response was quantitatively analyzed using the ImageJ 
software measuring the length, the number and the intersection points (IPs: are the 
intersections where the subintestinal vessels branch out) of SIVs from 6 different 
embryos from infected group and 5 different embryos from the control group. Compared 
to the negative control embryos, the infected and the positive control embryos had 
significantly more SIV (** p < 0.001) and IPs (* p = 0.003) (Fig. 3.8B), as well as 
significant lengthening of the SIVs (** p < 0.001 and * p = 0.002 for WT and positive 
control, respectively) (Fig. 3.8C). 
To determine if the observed angiogenesis was accompanied by a pro-
angiogenic response, the host response to Bh infection was assessed by qRT-PCR 
measuring the mRNA level of pro-inflammatory cytokines and pro-angiogenic markers 
in pools of 10 zebrafish embryos per group at 3 dpi. Those markers were selected due 
to their roles in tumor angiogenesis [230,249,250], and because they have been shown 
to be upregulated in Bh infection in in vitro models [1,53,77,83,251-253]. The data 
showed that the expression of IL-1b, IL-8 (Cxcl8), zVEGF165 (one of the dominant 
spliced isoforms of VEGF in zebrafish corresponding to human VEGF165 [222], Flk1 and 
angiopoietin-2 were upregulated by 4- to 23-fold in embryos inoculated with Bh WT 
compared to those inoculated with PBS phenol red (Fig. 3.7C). 
To determine if this angiogenic response was Bh-specific, embryos were 
microinjected at 28 hpf in the yolk sac with an average of 4 x 103 CFU of Bh 
pNS2T5DsRed2 or E. coli DH12S/pNS2T5DsRed2. At that particular dose E. coli 
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DH12S, a non-pathogenic strain, lead to a lethal infection in >90% of the embryos by 20 
hpi versus no death for Bh-injected and sham-injected embryos (data not shown). Our 
confocal microscopy showed evidence of dying embryos infected with E. coli compared 
to sham-injected and Bh infected embryos (Fig. 3.9). Thus, the lethal infection caused 
by E. coli precludes any assessment of an angiogenic response in these embryos. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Figure 3.7. Vessel sprouting and angiogenic marker expression in response to 
infection with Bh. (A) Subintestinal vessel morphology of embryos at 48 hpi: i) 
PBS/phenol red control; ii) embryos infected with approximately 3 x 103 GEs of 
Bh::DsRed2 (the overlay showing the RFP bacteria was omitted to help better visualize 
the subintestinal basket); inset image is the same infected embryos showing the 
presence of the red fluorescent bacteria at the site of infection; white arrows show SIV 
sprouting in the infected embryo; iii) Embryos injected with 10 ng rzfVEGF in the yolk 
sac near the developing subintestinal vessel. Images are representative of the pool of 
infected and control embryos imaged. Scale bar = 100 µm. (B) Length of SIVs for 
infected and control embryos at 2 dpi (measured from 200X images) (C) qRT-PCR of 
pro-angiogenic markers in zebrafish embryos infected with Bh. Results are expressed 
as the mean fold change in transcript levels of Bh-infected compared to uninfected 
control embryos at 3 dpi (n=2). 
 
A 
B C 
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Figure. 3.8. Vessel remodeling in zebrafish embryo infected with Bh. (A) Blood 
vessel morphology of Tg(fli1:egfp)y1 zebrafish embryos analyzed at 4 days post 
inoculation: i) PBS/phenol red control at 4 dpi; ii) embryos infected with 
Bh/pNST5DsRed2 visualized at 4 dpi (the overlay showing the RFP bacteria was 
omitted to help better visualize the subintestinal basket); white oval indicates the area 
of SIVs remodeling in infected embryos; inset image is the same infected embryos 
showing the presence of the red fluorescent bacteria at the site of infection; iii) 
embryos injected with 10 ng of rzfVEGF (positive control) in the yolk sac near the 
developing subintestinal vessel. Images shown are representative of the pool of 6 
embryos photographed from the infected group and 5 embryos photographed from 
the control groups. Scale bar = 100 µm. (B) Number of subintestinal vessel (SIV) and 
intersection points (IP) forming the subintestinal basket in the yolk sac from 6 
embryos (4 dpi) from each group (mean ± SEM), (** p < 0.001; * p = 0.003). (C) 
Length (in relative units) of SIVs (measured from 100X images) in the yolk sac from 6 
embryos (4 dpi) from infected group and 5 embryos from the control groups (mean ± 
SEM) versus negative control, (** p < 0.001; * p = 0.002). 
A 
B C 
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Genes                          Sequence (5’- 3’)            Source 
il-1b    For    ATCAAACCCCAATCCACAGAGT Rev   GGCACTGAAGACACCACGTT [185] 
il-8        For    TGTTTTCCTGGCATTTCTGACC 
       Rev   TTTACAGTGTGGGCTTGGAGGG 
 
[185] 
Vegf    For    TGCTCCTGCAAATTCACACAA     
       Rev   ATCTTGGCTTTTCACATCTGCAA 
[254] 
flk1    For    CACAAGAAGTCCAGCGATCA       
       Rev   CAGGGGACCACAAAATATGG 
[237] 
angptl2    For    GGTCATGGATGTTCCTTCAC      
   Rev   GTCCTGCTCAGTGGAAGGTG 
[233] 
ef1α     For    AGAAGGAAGCCGCTGAGATG     
        Rev   TGTCCAGGGGCATCAATAAT 
[105] 
rpl13a     For    TCTGGAGGACTGTAAGAGGTATGC 
        Rev   AGACGCACAATCTTGAGAGCAG 
[255] 
 
 
Figure 3.9. Infection of zebrafish embryo with E. coli versus Bh. Micrographs 
of Tg(fli1:egfp)y1 embryos at 24 hpi. Infected embryos were inoculated with an 
average of 4 x 103 CFUs of E. coli DH12S pNS2T5DsRed2 or Bh/pNS2T5DsRed2 
in the yolk sac at 28 hpf; control embryos were inoculated with PBS/phenol red. 
Images are representatives of pools of embryos micrographed. Scale bar 200 µm. 
 
Table 3.1. Primers used for qRT-PCR. 
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3.7. Bh infection induces expression of genes involved in cytoskeletal 
rearrangement, angiogenic and inflammatory responses 
The overall response of the zebrafish embryo to Bh was characterized by 
analyzing the total mRNA levels in infected embryos compared to controls by 
microarray using the GeneChip Gene 1.0 ST arrays designed by Affymetrix. This array 
was designed based on the most recent available zebrafish genome sequence. The 
gene chips were scanned and data were background adjusted, normalized and 
summarized by a Robust Multi-array Average (RMA) algorithm. In total, over 883 genes 
were upregulated by 2-fold or more, and 886 genes were downregulated by at least 2-
fold. While several of those genes are uncharacterized, many of them are involved in 
metabolic pathways, inflammatory response (IL1b, complement component c3c) and 
tissue remodeling (VEGF, IL-8). The fold change in gene expression of Bh-infected 
embryos compared to uninfected control embryos was calculated, and the candidate 
genes with a cut-off value of 1.9 or up were selected (Table 3.2). Some genes were 
also selected based on the evidence of their differential expression in Bh infection in cell 
culture models. A complete excel file of the microarray data can be accessed at 
http://www.liebertpub.com/zeb. The microarray result was validated by qRT-PCR on 
four genes (il8, il1b, vegf, api5) that are involved in either inflammatory response or 
angiogenic response to Bh infection of the zebrafish embryos using the remaining RNA 
prepared for the microarray experiment. The qRT-PCR result confirmed the 
upregulation of these genes due to infection of the zebrafish embryos with Bh (Table 
3.2). 
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Genes Accession number 
Microarray 
fold change 
qRT-PCR 
fold change Description/functions
1 
mapre3b 
 
NM_001002170 +7.07  Regulate dynamic of microtubule cytoskeleton 
Rho family 
GTPase 3a NM_199522 +2.29  
Regulate cytoskeletal 
dynamic 
Cdc42se1 NM_200060 +2.67  Cytoskeletal assembly 
IL-8 XM_001342570 +5.54 +2.6 
Facilitates migration of  
immune cells to inflammation 
site; angiogenesis 
IL1b NM_212844 +1.93 +21.3 
Inflammatory response, cell 
proliferation and 
differentiation 
VEGF NM_001044855 +1.92 +6 Cell proliferation; angiogenesis 
Apoptosis 
inhibitor 5 NM_199540 +4.23 +9.22 
Prevents apoptosis after 
growth factor deprivation 
FGF13a NM_001007399 +6.22  Cell growth; tissue repair 
E-cadherin NM_131820 +2.01  Calcium dependent adhesion molecule 
FGF receptor 1b NM_001161732 +5.20  Regulation of cell growth, formation of blood vessels 
Complement 
component c3c NM_001037236 -2.46  
Promotes phagocytosis 
during an inflammatory 
response against pathogens 
FGF2 NM_212823 -3.78  Cell survival; angiogenesis 
Interferon 
regulatory factor 
2a 
 
NM_207054 -2.18  
Regulate transcription of 
interferon through the JAK-
STAT signaling pathway 
Table 3.2. Selected genes involved in response to infection with Bh. 1The 
description and function of these genes are in humans. Fold change indicates Bh-
infected compared to uninfected controls. Some genes have the same function in 
zebrafish as in humans; however, the functions of some of these genes have not yet 
been fully investigated in the zebrafish model. 
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3.8. Infection pattern of Bh ∆badA and ∆virB mutants in the zebrafish embryo   
To further characterize Bh infection and the importance of BadA and VirB/VirD4 
T4SS in Bh pathogenesis and survival in the zebrafish embryo host, embryos were 
staged at 28 hpf and microinjected with 3 x 103 Bh Houston-1 containing in-frame 
deletions for full-length badA (ΔbadA/pNS2T5DsRed2) or virB operon (ΔvirB2-
11/pNS2T5DsRed2). Microscopy results indicated that both the ΔvirB mutant and the 
ΔbadA mutant could survive in the embryos with peak fluorescence observed at 3 dpi, 
although the levels of red fluorescence in the mutants was not as strong as in the wild 
type (Fig. 3.10A). 
In a subsequent experiment, zebrafish embryos were randomly grouped and 
inoculated with an average of 7.4 x 103 Bh pNS2T5DsRed2, 5.4 x 103 ΔvirB2-11 
pNS2T5DsRed2, and 6.7 x 103 ΔbadA pNS2T5DsRed2. Bacterial infection was 
evaluated by qPCR at different time points. Wild-type bacteria were able to replicate, 
with GE increasing to over 2 x 105 in four days and remained detectable throughout the 
duration of the experiment. In contrast, the ΔvirB deletion mutant appeared to follow the 
same infection pattern but exhibited a reduced number of GE/embryo and a shorter 
duration of infection. Further, the ΔbadA deletion mutant did not appear to replicate as 
well compared to the WT and the ΔvirB mutant in the infected embryos (Fig. 3.10B). 
Although there was some variability in the number of bacteria in the initial inocula, 
significantly higher numbers of GEs (** p < 0.016, ** p < 0.016, * p < 0.05, and *** P < 
0.008 at days 2, 3, 4 and 5, respectively) were detected in embryos infected with the 
WT than observed in those inoculated with ΔvirB and ΔbadA mutants.  
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Figure 3.10. Zebrafish embryos infected with Bh ∆badA and ∆virB mutants. (A) 
Confocal micrographs of Tg(fli1:egfp)y1 transgenic embryos infected with 3 x 103 CFU 
BhΔbadA/pNS2T5DsRed2 compared to the WT expressing DsRed2. All strains persist 
in the embryos at least 5 days post-infection with a peak fluorescence observed at 3 
dpi with the fluorescence intensity is at least twice as much in the WT-infected 
compared to the mutant-infected embryos. All images shown are representative of the 
pool of embryos imaged.  Scale bar = 100 µm. (B) Infection pattern in zebrafish 
embryos inoculated at 28 hpf with 6.7 x 103 CFU of BhΔbadA/pNS2T5DsRed2 or 7.4 x 
103 CFU of Bh/pNS2T5DsRed2 and 5.4 x 103 ΔvirB2-11 pNS2T5DsRed2. The means 
of GEs between infected groups were calculated by qPCR at different time points 
(mean ± SEM; * p < 0.05, ** p < 0.016 and *** P < 0.008).  
 
A 
B 
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3.9. The Bh ∆badA and ∆virB mutants exhibit an attenuation response in vivo  
The response to infection in pools of embryos inoculated with the ∆virB mutant 
was investigated by qRT-PCR at day 3 post-infection. Compared to embryos inoculated 
with WT those inoculated with ∆virB mutant displayed a reduced induction of IL-8 by 
1.6-fold, IL-1 by 1.5-fold, VEGF by 1.7-fold, FLK1 by 1.8 fold and angiopoietin by 10.8-
fold (Fig.3.11A). In independent experiments, the response to infection in pools of 
embryos inoculated with the ∆badA mutant was also assessed by qRT-PCR. Embryos 
inoculated with the ∆badA mutant showed a reduced induction of IL-1 by 7-fold and pro-
angiogenic markers IL-8, zVEGF165, Flk1 and angiopoietin-2 by 2.5-fold, 2-fold, 3-fold, 
and 2-fold, respectively (Fig. 3.11B). Both mutants displayed diminished ability to 
induce a pro-inflammatory response as well as a pro-angiogenic response compared to 
the WT. However, except for angiopoietin, a greater difference in expression of those 
markers was observed when embryos were inoculated with ∆badA mutant.  
  
Figure 3.11. Response to infection with Bh ∆badA and ∆virB mutants. (A) Differential 
expression in pro-inflammatory genes and pro-angiogenic factors by qRT-PCR in pools of 
embryos infected with ΔvirB compared to WT. Results are expressed as the mean fold 
change of WT-infected or ΔvirB mutant-infected compared to uninfected control embryos at 
3 dpi (n=2). (B) Differential expression in pro-inflammatory genes and pro-angiogenic 
factors by qRT-PCR in pools of embryos infected with ΔbadA compared to WT. Results are 
expressed as the mean fold change of WT-infected or ΔbadA mutant-infected compared to 
uninfected control embryos at 3 dpi (n=2).  
A B 
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Chapter 4 
Discussion 
Bartonella are facultative intracellular pathogens with over thirty species 
described that infect a range of mammalian hosts [6,8]. Bh, B. quintana and B. 
bacilliformis are the species most commonly known to cause human disease. 
Depending on the immune status of the infected individual, Bh infection can span the 
range of self-limiting cat scratch disease (CSD) to the more serious and life-threatening 
bacillary angiomatosis (BA) [7]. A unique aspect of some Bartonella species is their 
ability to induce blood vessel proliferation in humans characterized by blood-filled 
capillaries resulting from systemic infection [47]. The angiogenic response induced by 
Bh in patients with BA is believed to be a multi-step process that involves the 
proliferation of endothelial cells, inhibition of endothelial cell apoptosis, and angiogenic 
reprogramming of infected host cells. The BadA and the VirB/VirD4 T4SS proteins of Bh 
are thought to play a leading role in eliciting an angiogenic host response during 
infection [52,76,81,83]. 
Although much is known about Bh and those virulence factors from studies using 
in vitro systems, their molecular mechanisms and overall contribution to Bh 
pathogenesis remains elusive and can only be fully understood by using an in vivo 
model. Therefore, there has been a great need for a practical animal model to study Bh 
pathogenesis and host response. To date, efforts to establish a suitable in vivo model to 
study Bh pathogenesis have been unsuccessful. The fact that zebrafish have a well-
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developed immune system with many similarities to mammalian systems make them an 
attractive model of human diseases. The zebrafish embryo is a proven model for 
bacterial pathogenesis; moreover, their transparency and the availability of the 
Tg(fli1:egfp)y1 transgenic strain with GFP-labeled vasculature has provided a unique 
opportunity to study Bh infection and its distinctive ability to induce vessel proliferation.  
We have determined the conditions necessary to maintain a sustained infection 
with Bh, including the appropriate route of infection, dose and site of inoculation, the 
proper stage of development of the embryos, and the means of enumerating bacteria 
after infection. We have found that inoculation of Bh into the yolk sac as compared to 
the blood circulation leads to a more persistent infection. It has been reported that yolk 
sac infections with fast-growing bacterial species have resulted in massive bacterial 
growth and early death of embryos [106,107]. The yolk sac is perhaps preferred by Bh 
because it is a fastidious and slow growing bacterium; the yolk sac may provide the 
nutrients needed and enough time to adapt to the new environment before facing a 
strong antimicrobial response. Furthermore, we have determined that zebrafish 
embryos Tg(fli1:egfp)y1 sustained a consistent infection pattern when microinjected at 
24 - 28 hpf in the yolk sac with an inoculum of approximately 3 x 103 GEs of Bh.  
One area, which proved problematic, was bacterial enumeration of Bh via plating 
of embryo homogenates. This assay provides direct counts of the number of viable 
bacteria in the embryos. However, the autoagglutination of the bacteria as well as 
contamination seen even on kanamycin selective media plates caused some variability 
in enumeration as evidenced by the error bars (Fig. 3.3A). This contamination is likely 
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in part due to the normal flora present in the embryos. In addition, rapidly growing 
water-borne bacteria and fungi that are resistant to kanamycin also proved problematic 
since Bh requires at least 5 days for colonies to appear on plates; the contaminants 
usually grew much faster and often prevented accurate plate counting. Therefore, we 
alternatively used both confocal microscopy to qualitatively visualize Bh in embryos and 
qPCR to assess the GE/infected embryo. This method is more sensitive as it uses 
primers specific to the Bh NADH dehydrogenase subunit G gene to quantify the 
genomic equivalents of bacteria per embryo. It is likely these primers amplify DNA from 
nonviable bacteria; however, there is a notable reduction in GEs from day 4 to day 6 
suggesting that gDNA from dead bacteria degrades and is not amplified by qPCR (Fig. 
3.3B). This reduction pattern in GEs was similar to that observed by microscopy (Fig. 
3.2) and by CFU counts in previous experiments (Fig. 3.3A). Despite the possible 
detection of nonviable bacteria, the qPCR method proved to be far more consistent and 
reliable than the plating method. 
Much of the understanding of the mechanisms required for angiogenesis has 
been derived from cancer models. Like in cancer, Bh infection of endothelial cells 
induces the activation of HIF-1α and subsequent secretion of angiogenic factors such 
as VEGF leading to cell proliferation and angiogenesis [76,78]. An in vivo model is 
critical since multiple cell types including endothelial cells, macrophages and epithelial 
cells are thought to contribute to Bh-mediated angiogenesis via the paracrine loop 
model [1,77]. We have shown that aggregates of Bh do interact with the EC of the 
embryo with some intracellular bacteria observed. However, many are distant from the 
EC in the yolk sac and it is difficult to accurately quantify the number of intracellular Bh 
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in infected embryos. It should be noted that in humans, histological studies of samples 
from bacillary angiomatosis patients have shown very few intracellular Bh and that most 
of the bacteria are seen as epicellular [60]. 
Histological examination of bacillary angiomatosis lesions from patients with Bh 
infection have shown the infiltration of polymorphonuclear cells and macrophages 
located in close proximity to the proliferating endothelial layer [60,61]. Our evidence 
shows that Bh infection induces migration and accumulation of neutrophils and 
macrophages at the site of infection. This result is in agreement with what was observed 
in tissue samples as well as what has been shown in in vitro studies revealing the role 
of phagocytic cells in Bh pathogenesis [1]. There must be a balance between Bh 
causing phagocytic cells to produce proangiogenic factors and at the same time 
suppress bacterial killings. Although the yolk sac may be considered as a site of relative 
immune privilege in the zebrafish embryo, a robust innate response against infection 
has been described in the yolk sac, and macrophages and neutrophils have been 
observed ingesting bacteria in both the blood circulation and the yolk sac 
[106,107,195,256]. We hypothesize that the resistance to a lethal infection by Bh from 
infected embryos is very likely due to the activation of an innate immune response. 
While our real-time observation of Bh-infected zebrafish embryos showed an 
accumulation of phagocytic cells at the site of infection, the role of these cells in killing 
Bh was not clearly demonstrated. It remains to be investigated whether or not this is 
due to the ability of this bacterium to inhibit phagocytosis. 
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An angiogenic phenotype was observed in our transgenic zebrafish embryo 
model when infected with Bh. It was characterized by an increase in length and number 
of the subintestinal vessels and intersection points at the site of infection in the infected 
compared to controls. Moreover, disruption of the smooth and normal pattern of those 
vessels could also be observed. Although the extent of the phenotypic response 
observed is not as dramatic as what is seen in tumor angiogenesis, a similar response 
was observed in the zebrafish yolk membrane angiogenesis assay developed by Nicoli 
et al. [110,257]. The angiogenic phenotype observed in the infected embryos was 
further substantiated by qRT-PCR analysis showing the induction of proangiogenic 
factors such as IL-8 (Cxcl8), zVEGF-165, zVEGFR2 and angiopoietin-2 in the infected 
compared to control embryos. These potent angiogenic factors have been shown to 
stimulate EC proliferation and angiogenic phenotypes in response to Bh infection in vitro 
[77,251,253]. Our efforts to use E. coli DH12S strain as a negative control for an 
angiogenic response in the zebrafish embryo was unsuccessful as embryos inoculated 
with E. coli in the yolk sac died within 20 hours post-inoculation. The death of the 
embryos may be a result of septic shock due to the high endotoxicity of bacterial 
lipopolysaccharide (LPS) of E. coli compared to the remarkably low endotoxicity of LPS 
of Bh [90]. 
Our microarray data provide evidence that there are many genes that are 
involved not only in inflammatory and angiogenic responses, but also in cytoskeletal 
rearrangement and metabolic processes. This suggests that the bacteria have a 
widespread impact on host gene expression patterns. Bh entry into EC and epithelial 
cells can happen by two alternative routes: single bacterium uptake via a zipper-like 
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mechanism or in the form of large bacterial aggregates in a structure called invasome 
[8,54]. The zipper-like mechanism has been documented in several bacteria including 
Listeria monocytogenes. It has been shown that the entry of L. monocytogenes into 
epithelial cells requires the interaction of the internalin protein with E-cadherin on the 
host cell [258]. In addition to its role in cell-cell adhesion and involvement in early tissue 
formation in zebrafish embryo [259], E-cadherin may also play a role in Bh entry into the 
host cell as Bh infection induces an upregulation of the gene encoding for E-cadherin 
protein. Formation of the invasome structure leading to the uptake of Bh aggregates 
was shown to be dependent in part on the expression of small Rho family GTPases and 
CDC42 [260]. Rho family GTPase 3a and CDC42 small effector 1 (Cdc42se1) were 
upregulated in the infected embryos suggesting that they may play a role in Bh-host 
interactions.  
Antimicrobial peptides such as β-defensins, hepcidin, and phosvitin are an 
important component of the innate immunity. In vitro killing of pathogens with purified 
antimicrobial peptides from zebrafish embryo extracts have been reported [208,209]. In 
vitro exposure of Bh to zebrafish embryo crude extracts promotes bacterial growth, 
which may be due to the nutrients found in the embryo extracts. Although we do not rule 
out the protective role of antimicrobial peptides in zebrafish extract, it seems like the 
nutrients in the extracts outweighs their bactericidal effect on the Bh survival in vitro. 
Moreover, Bh infection did not seem to induce their expression in vivo as evidence in 
the microarray data showed that their transcript levels did not vary between the infected 
and control groups embryos. 
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Bh-induced angiogenesis is a multi-step process that partly depends on the 
expression of BadA protein which induces proangiogenic cell response via activation of 
HIF-1 and NF-kB, and the subsequent secretion of VEGF and IL-8, respectively [76-78]. 
Bh-induced angiogenesis in the zebrafish embryo may occur through the same pathway 
as previously shown in cell culture studies as those genes, including HIF-α 
(NM_2002233) and NF-Кβ (NM_203184), were seen to be upregulated in the infected 
embryos in the microarray data (data not shown). Some notable genes that were down-
regulated in the infected embryos include FGF2, which plays an important role in cell 
survival and angiogenesis, and complement component c3c, which is involved in 
promoting phagocytosis during an inflammatory response against pathogens [261-263]. 
Although FGF2 expression in Bh-induced angiogenesis has not been fully investigated 
in vitro, it is somewhat surprising that the infection with Bh would suppress its 
expression. On the other hand, Bh has been shown to inhibit phagocytosis [15], so it is 
not surprising that the evidence shows that expression of complement component c3c is 
suppressed by Bh infection in the zebrafish embryos. 
As in many pathogenic bacteria, the VirB/VirD4 T4SS along with the Bartonella 
effector proteins have been shown to play important roles in Bh pathogenesis in vitro 
[79,82]. The expression of the VirB T4SS and some of the effector proteins have been 
associated with inflammatory cytokine production and pro-angiogenic activities [83,84]. 
A deletion mutant for genes encoding the VirB T4SS (∆VirB2-VirB11) supports bacterial 
replication in the zebrafish embryos although to a lesser extent than the WT bacteria. 
These data suggest that the VirB machinery and even its cognate effectors are not an 
absolute requirement for establishing an infection in the zebrafish embryo model. 
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However, an abrogated response to infection with the ΔvirB mutant is observed in the 
embryos; this further indicates that although the VirB T4SS is not absolutely required for 
Bh survival in the zebrafish embryo, it may play a role in the pathogenicity of Bh in vivo.  
The genome of Bh contains at least two forms of BadA-encoding genes: the full-
length version (BH01510), which was the gene deleted in the mutant used in this study, 
and a truncated version (BH01490). It has been reported that some Bh isolates do not 
express a functional BadA, and due to passaging histories, defined Bh strains may 
exhibit distinct characteristics and infection phenotypes [264]. However, our Bh 
Houston-1 strain was early passage and displayed a rough phenotype which correlates 
with the presence of full-length BadA protein which was further confirmed by reactivity 
with antibody specific for BadA (data not shown). While a deletion mutant for the major 
trimeric autotransporter adhesin BadA appears to increase in fluorescence intensity 
within the embryos over time, qPCR data indicated that this mutant was unable to 
replicate and remained at a relatively constant bacterial burden as determined by the 
GE/embryo. It has been reported that full-length BadA is essential for Bh adhesion to 
host cells and extracellular matrix proteins leading to a direct angiogenic response by 
stimulating HIF-1α production and VEGF secretion [76-78]. Therefore, we hypothesized 
that, in absence of full-length BadA, Bh’s ability to adhere to target cells, establish 
infection and initiate the induction of an angiogenic response would be hampered. Our 
data showed that the Bh mutant for full-length BadA exhibited an abrogated angiogenic 
response in the zebrafish embryo compared to WT although it may be possible that the 
diminished ability of this mutant to replicate in the zebrafish embryos precluded the 
establishment of a pro-angiogenic host response. Thus, our in vivo data support a major 
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role for BadA in establishing infection and also possibly inducing a pro-angiogenic host 
response. Although the function of the truncated version of BadA (BH01490) in Bh has 
not been fully investigated, a compensatory role in inducing an angiogenic phenotype 
following the loss of full-length BadA can’t be eliminated in the ΔbadA mutant.  
In conclusion, we have developed an animal model to study Bh infection and 
pathogenesis. We demonstrated that zebrafish embryos microinjected in the yolk sac 
became infected with Bh and exhibited evidence of an angiogenic response as well as 
an inflammatory response involving recruitment and accumulation of neutrophils and 
macrophages to the site of infection. We found that the Bh mutants for virB T4SS and 
the full-length BadA induced abrogated pro-inflammatory and pro-angiogenic responses 
when compared to the WT in the zebrafish embryo. Moreover, we also found that the 
full-length BadA mutant showed a limited ability to replicate when compared to the WT 
suggesting that this in vivo model is a useful system in which to assess virulence. The 
infection pattern with Bh was not assessed beyond day 8 post-inoculation as embryos 
are capable of obtaining nutrition from the yolk sac during this time period and extension 
of the period of infection would require supplemental food sources – possibly 
introducing microbial contaminants. Regardless, we believe that the use of zebrafish 
embryos as a model of Bh infection proved highly successful and provided valuable 
insight which can only be gathered from an in vivo model system.  
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Chapter 5 
Future Studies 
 Although the Bh mutant for full-length BadA exhibited an abrogated response in 
the zebrafish embryo, because a compensatory role of the short version of BadA 
following the loss of full-length BadA may be at play in the ΔbadA mutant, future studies 
should focus on making a double knock out of both the full-length and the truncated 
versions of BadA and study their roles in Bh infection. It has been assumed that BadA 
and the VirB/D4 T4SS may act synergistically in that the BadA-induced adhesion to host 
cells brings the bacteria and the host cells into close proximity facilitating the secretion 
of the effector proteins by the VirB/D4 T4SS [64]. Although the synergistic effect of 
those two important virulence factors in Bh has not been elucidated in vitro, it would be 
interesting to investigate the effect of a double knock out mutant of those genes on Bh 
pathogenesis in the zebrafish embryo. Moreover, studies complementing the genes into 
the respective knock out strains will be important in confirming that the phenotypic and 
or genotypic effects are due to the respective genes. 
Bh infection induced migration of phagocytic cells to the site of infection. 
Interestingly, although the phagocytic cells were recruited to the infection site, the 
majority of the bacteria were not phagocytized. The role of those phagocytes in 
clearance of the bacteria remains to be determined. The myeloid cells can be depleted 
in the zebrafish embryos using morpholino knockdown of the myeloid transcription 
factor Pu.1, which has been shown to be required for myelopoiesis in zebrafish [212]. 
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The infection pattern and the response to infection with Bh could then be studied in the 
macrophage- and neutrophil-depleted embryos. Moreover, since there is a dramatic 
decrease in bacterial burden starting at day 4 or 5 post infection, there may be a 
respiratory burst killing of the bacteria by the zebrafish embryo immune system. The 
production of reactive nitrogen and reactive oxygen species is an important effector 
mechanism of the innate immunity in response to infection of the zebrafish embryo. The 
role of respiratory burst killing in clearance of the bacteria by the embryos can be 
assessed by an assay measuring the oxidation of 2′,7′-dihydrodichlorofluorescein 
diacetate (H2DCFDA), a non-fluorescent dye, to a fluorescent product 
dichlorofluorescein (DCF) [265]. 
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